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ABSTRACT 
 
Drug use among adolescents is one of the nation’s most significant public health concerns, with 
an estimated 47% to 56% of adolescents engaging in illicit substance use before completing high 
school. Negative consequences often associated with adolescent substance use frequently result 
in severe emotional and physical problems and serve to illustrate the growing importance of 
identifying associated risk factors. It is likely that psychological risk factors play an important 
role in the initiation and continued use of drugs among adolescents. In particular, mood and 
anxiety disorders have emerged as two such psychological risk factors. Unfortunately, studies 
examining this relationship have almost exclusively focused on clinical populations. 
Additionally, the few studies examining this relationship among community samples tend to be 
limited in minority representation, especially with regard to minority youth residing in a rural 
geographical location. As such, the current study aimed to elucidate the relationship between 
depression and anxiety and adolescent substance use among a sample of diverse adolescents 
residing in a predominantly rural geographical location. Findings demonstrate the significant role 
of depression and anxiety above and beyond relevant sociodemographic variables (SES, gender, 
ethnicity, and grade level) in predicting lifetime substance use among this unique population. 
Findings extend previous research and suggest the need for early prevention initiatives aimed at 
both adolescent substance use and psychological correlates such as depression and anxiety.    
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Comorbid Depression and Anxiety as Predictors of Adolescent Substance Use in a Rural and 
Ethnically Diverse Community Sample 
Prevalence and Impact of Adolescent Substance Use  
Alcohol and drug use among adolescents is one of the nation’s most significant public 
health concerns. It is estimated that between 47% and 56% of adolescents have engaged in illicit 
substance use before completing high school (Johnston, O’Malley, Bachman, & Schulenberg 
2009; Substance Abuse and Mental Health Services Administration [SAMHSA], 2009). Findings 
from the Monitoring the Future Project, an annual national investigation of adolescent drug use 
conducted by the National Institute on Drug Abuse (NIDA), provide specific information 
regarding prevalence rates of both licit and illicit substances from roughly 35,000 8th, 10th, and 
12th graders across the United States (Johnston et al., 2009). This study demonstrated that by 8th 
grade, 19.6% of youths have engaged in the use of at least one illicit drug. This lifetime 
prevalence of illicit substance use increases to 34.1% by 10th grade and 47.4% by 12th grade 
(Johnston et al., 2009). Equally striking are the rates of illicit substance use when excluding 
marijuana. That is, 11.2% of 8th graders, 15.9% of 10th graders, and 24.9% of 12th graders have 
engaged in the use of an illicit substance other than marijuana at least one time (Johnston et al., 
2009). Rates are even higher with regard to licit substances such as tobacco and alcohol. For 
example, 20.5% of adolescents have smoked a cigarette by 8th grade, with 44.7% having smoked 
a cigarette by 12th grade. Additionally, 38.9% of 8th graders have engaged in alcohol use at least 
once, with 18% endorsing having been drunk. This rate of lifetime alcohol use increases to 
71.9% by 12th grade, with 54.7% having been drunk at least once by this time (Johnston et al., 
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2009). These rates of lifetime licit and illicit substance use demonstrate a need for increased 
awareness and continued observations of substance use among a broad range of adolescents.  
Regarding current (within the past 30 days) substance use, data from the 2008 National 
Survey on Drug Use and Health (NSDUH) indicated that an estimated 20.1 million Americans 
ages 12 or older (8% of the population) have engaged in use of marijuana/hashish, cocaine, 
crack-cocaine, heroin, hallucinogens, inhalants, or prescription medication misuse within the past 
month. These rates of current drug use have remained constant over time and are consistent with 
data from annual reports of past years (SAMHSA, 2009). Specifically, 9.3% of youths between 
12 and 17 are current illicit drug users (SAMHSA, 2009). Additionally alarming are findings that 
indicate the availability of illicit substances for adolescents. Studies have shown that 13% of 
adolescents aged 12 to 17 reported that it would be “fairly easy” or “very easy” to obtain heroin, 
with other illicit substances including LSD, cocaine, and marijuana being even more readily 
available (SAMHSA, 2009). These high rates of substance use, as well as the ease with which 
they are obtained, may contribute to current high rates of substance-related disorders. Indeed, an 
estimated 22.2 million Americans (8.9% of the population) aged 12 or older met diagnostic 
criteria for past year substance abuse or dependence as classified by the Diagnostic and 
Statistical Manual of Mental Disorders, 4th edition (DSM-IV; American Psychiatric Association, 
2004). Of these individuals, 7.0 million abused or were dependent on illicit drugs, with nearly 
half of these (3.1 million) meeting criteria for abuse or dependence on both alcohol and illicit 
drugs. Strikingly, approximately 7.6 percent of adolescents between 12 and 17 years of age meet 
criteria for substance abuse or dependence (SAMHSA, 2009).  
Given the high rates of illicit substance use among adolescents, as well as the relative 
availability of illicit drugs, negative consequences associated with adolescent substance use are 
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especially relevant and frequently result in severe emotional and physical problems. Adolescent 
substance use has been shown to have both short- and long-term societal consequences. 
Specifically, adolescent substance use is financially demanding on the health care system, the 
public education system, and a host of mental health services (e.g. alcohol and drug treatment 
programs). In fact, in 2009, roughly $14 billion were allocated by the federal government for the 
prevention and treatment of substance use in the United States (Office of National Drug Control 
Policy, 2009).  
Alcohol and drug problems among adolescents are often associated with more immediate 
consequences such as increased sexual risk taking behaviors (e.g., high-risk sexual activity), 
delinquency, and conduct problems at home and school (Feldstein & Miller, 2006). For example, 
adolescents being treated for substance use problems report earlier onset of sexual activity, a 
greater number of sexual partners, and lower rates of condom use compared to peers not in 
treatment for substance use (Tapert, Aarons, Sedlar, & Brown, 2001). Additionally, adolescents 
identified as high risk for a diagnosis of alcohol and drug abuse/dependence are more likely to 
engage in sexual contact after using drugs or alcohol or to be with a sexual partner who has 
engaged in drug or alcohol use (Levy, Sherritt, Gabrielli, Shrier, & Knight, 2009). Further, 
longitudinal evidence suggests that early onset adolescent alcohol use is associated with earlier 
age of sexual intercourse as well as a higher number of sexual partners by adulthood (Strachman, 
Impett, Henson, & Pentz, 2009). Research has also demonstrated an association between drug-
related problems and risk for contracting HIV (Ellickson, Colling, Bogart, Klein, & Taylor, 
2005). Although essential in a comprehensive understanding of risk factors associated with 
adolescent substance use, acute sexual risk factors likely comprise only a subset of the risk 
factors closely tied to adolescent substance use.  
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 In addition to a heightened propensity for sexual risk taking behaviors, adolescents who 
engage in substance use at an early age are at increased risk for other problem behaviors. For 
example, associations have been found between early adolescent substance use and increased 
risk behaviors such as carrying a weapon to school and engaging in physical fights (DuRant, 
Smith, Kreiter, & Krowchuk, 1999). Studies have shown that individuals who initiate substance 
use at earlier ages tend to earn poorer grades and have lower academic intentions compared to 
those who refrain from use until late adolescence (Ellickson, Tucker, Klein, & Saner, 2004). 
Early onset substance use is also associated with suicide attempts and suicidal ideation. In a 
study conducted by Cho, Hallfors, and Iritani (2007), onset of substance use was found to be 
associated with several suicide risk indicators such as suicidal ideation, personal endorsement of 
suicide, and suicide attempts. Although an abundance of general negative consequences clearly 
exists among adolescent substance users, substance characteristics and effects vary considerably. 
As a result, the observed consequences associated with substance use likely differ as a result of 
the specific substance used. The following text highlights the impact of specific substances 
among adolescents.   
Specific Substances and Their Impact among Adolescents 
Tobacco. Cigarette smoking and other tobacco product use (e.g., chewing tobacco, snuff, 
etc.) is very common. Indeed, in 2001 there were more than 46 million smokers in the United 
States (U.S. Department of Health and Human Services, 2004). Cigarette smoking is equally 
common among youths, with an estimated 5,000 adolescents each day smoking for the first time 
(U.S. Department of Health and Human Services, 2004) and 20.4% of 12th graders smoking at 
least once within the past 30 days (Johnston et al., 2009). Nicotine dependence as a result of 
tobacco use can be very addictive and is marked by severe craving as well as withdrawal 
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symptoms such as dysphoric or depressed mood, insomnia, irritability, frustration, anger, 
anxiety, difficulty concentrating, restlessness or impatience, decreased heart rate, and increased 
appetite or weight gain (American Psychiatric Association, 2004). Nicotine craving and 
withdrawal symptom severity increases considerably prior to a relapse following a quit attempt, 
suggesting that these factors play a role in the maintenance of smoking and nicotine use (Allen, 
Bade, Hatsukami, & Center, 2008). Further, as nicotine dependence increases, smoking cessation 
becomes extremely difficult, with higher levels of nicotine dependence producing stronger 
craving and more severe withdrawal symptoms (Bailey et al., 2009).  
Adolescent smoking is of particular relevance given findings that adolescent smoking 
increases the risk for adult smoking (Chassin, Presson, Sherman, & Edwards, 1990). Further, 
adolescent smoking likely plays a significant role in the onset and severity of more illicit 
substance use (Henningfield, Clayton, & Pollin, 1990). For example, cigarette use often precedes 
the onset of illicit substance use for individuals who use marijuana, cocaine, or crack-cocaine 
(Kandel & Yamaguchi, 1993).  In addition to being among the leading causes of death in the 
United States (Mokdad, Marks, Stroup, & Gerberding, 2004) tobacco use occurs at high rates 
with psychiatric disorders such as major depressive disorder (MDD; Brown, Lewinsohn, Seeley, 
& Wagner, 1996). 
Alcohol. Alcohol use is one of the most commonly used substances among adolescents. 
By 8th grade, 38.9% of adolescents have engaged in alcohol use. By 12th grade, this rate nearly 
doubles to 71.9%, with roughly 43% engaging in alcohol use regularly (Johnston et al., 2009). 
These rates are coupled with evidence demonstrating that alcohol is frequently used in excessive 
amounts among adolescents. Indeed, binge drinking and high-risk use occur in over 20% of 
adolescents 12 years of age or older (Patton et al., 2007; SAMHSA, 2009). By 8th grade, 18% of 
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adolescents report having been drunk, a rate that increases to 54.7% by 12th grade (Johnston et 
al., 2009). Although prevalent, patterns of alcohol use differ considerably among adolescents. 
For example, Colder, Campbell, Ruel, Richardson, and Flay (2002) identified several distinct 
trajectories of adolescent substance use (occasional very light drinkers, escalators, occasional 
heavy drinkers, rapid escalators, and heavy drinkers with declining frequency), which 
differentially predicted alcohol related problems; however, relatively few studies have examined 
the effect of alcohol use progression on treatment or related outcomes (Deas, 2008).  
As one of the most frequently and heavily used substances among adolescents, alcohol is 
associated with increased use of other licit and illicit substances as well as a multitude of 
negative consequences. For example, adolescent alcohol use is often associated with an increased 
likelihood of sedative, stimulant, and opiate use. Additionally, studies demonstrate that 
compared to non-drinkers, adolescents with alcohol dependence are 10 times more likely to 
experience another drug use disorder and 4.5 times more likely to have an affective disorder 
(Degenhardt, Hall, & Lynskey, 2001). In addition to risk for use of other substances, adolescent 
alcohol use has also been associated with violent and delinquent behaviors (Komro, Williams, 
Forster, Perry, Farbakhsh, & Stigler, 1999), higher risk for automobile crashes (Dunlop & 
Romer, 2010), and increased suicidal ideation and suicide attempts (Bagge & Sher, 2008; 
Schilling, Aseltine, Glanovsky, James, & Jacobs, 2009).  
Marijuana. Marijuana is quite easy for adolescents to procure; that is, 83%-90% of 12th 
graders describe marijuana as “fairly easy” or “very easy” to obtain if desired. Additionally, 
marijuana has a relatively low perceived level of harmfulness among adolescents, with only 
25.8% of 12th graders describing occasional marijuana use as a great risk for physical or other 
harm (Johnston et al., 2009). As a result, marijuana is the most commonly used illicit substance 
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among adolescents. By 8th grade, 14.6% of adolescents have engaged in marijuana use at least 
once. This rate increases considerably to 42.6 % by 12th grade, with 19.4% of 12th graders using 
marijuana within the past month (Johnston et al., 2009). Marijuana, derived from the cannabis 
plant, contains delta-9-tetrahydrocannabinol (THC), which produces psychoactive effects in the 
brain and central nervous system (American Psychiatric Association, 2004). Marijuana 
dependence can occur with and without physiological dependence. Psychological withdrawal 
symptoms following abstinence from use may include irritability or anxious mood, with the 
possible experience of physiological effects such as tremors, perspiration, nausea, changes in 
appetite, and sleep disturbances (American Psychiatric Association, 2004). Additionally, 
increases in aggression are common following abstinence of use among chronic users (Kouri, 
Pope, & Lukas, 1999).  
Although marijuana use is rarely perceived to be harmful, extended use may have evident 
negative consequences. Heavy marijuana use is associated with deficits in attention, learning, 
and memory (Jacobus, Bava, Cohen-Zion, Mahmood, & Tapert, 2009). For example, Medina, 
Hanson, Schweinsburg, Cohen-Zion, Nagel, and Tapert (2007) found that marijuana users 
demonstrated slower psychomotor speed and poorer attention, memory, and sequencing ability 
compared to adolescent non-using controls. In a related vein, adolescent marijuana use has been 
linked to poorer school performance and heightened risk for school drop-out (Lynskey, Coffey, 
Degenhardt, Carlin, & Patton, 2003; Lynskey & Hall, 2000). Existing evidence also suggests that 
marijuana use has emotional effects. Adolescents who engage in marijuana use may 
differentially respond to and process emotion related stimuli (Gruber, Rogowska, & Yurgelun-
Todd, 2009) and experience elevated levels of depression (Medina, Nagel, Park, McQueeny, & 
Tapert, 2007) compared to non-using controls. Further, in a study conducted by Lynskey et al. 
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(2004), adolescents who meet criteria for cannabis dependence displayed elevated rates of major 
depressive disorder (MDD), suicidal ideation, and suicide attempts compared to their non-
dependent twin counterparts. Although marijuana is used at high rates and is generally 
characterized by a low level of perceived harmfulness, a growing body of research has emerged 
identifying a number of negative consequences associated with adolescent marijuana use. 
Cocaine/Crack-cocaine. Current cocaine use among adolescents is relatively low (i.e., 
only 0.4% of youths aged 12 to 17 have engaged in cocaine use within the past month; 
SAMHSA, 2009) and generally does not progress to more frequent or heavier use (Brower and 
Douglas, 1987). However, cocaine, both powder and crack-cocaine, has been used at least once 
by 5% of 8th graders. This rate doubles by 12th grade, with roughly 7.8% of seniors reporting 
cocaine use and 2.8% reporting crack-cocaine use at least once (Johnston et al., 2009). Although 
effects vary by level of potency, cocaine is the active ingredient in all forms of use (American 
Psychiatric Association, 2004). Several risk factors such as preexisting psychiatric disorders, 
ADHD, and psychosocial development have been indicated in adolescent cocaine use (Brower & 
Douglas, 1987). Additionally, following fist occurrence of use, adolescents may be at greater risk 
than adults for cocaine craving, which may facilitate continued use. For example, Kilgus, 
Pumariega, and Seidel (2009) found that auditory and visual cocaine-related environmental cues 
increased craving in both adolescents and adults but that adolescents displayed higher craving at 
baseline and higher peak craving compared to adults.  
Cocaine and crack-cocaine use among adolescents has been associated with numerous 
negative consequences. For example, among adolescents in treatment for cocaine use, 80% 
reported experiencing at least one negative consequence as a result of cocaine use (Hickey, 
Brown, Chung, Kolar, & Michaelson, 1991). In a study conducted by Tolou-Shams, Feldstein 
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Ewing, Tarantino, and Brown, 2010, increased rates of sexual activity and STDs, as well as 
inconsistent condom use was associated with adolescents with psychiatric disorders who had at 
least one occurrence of cocaine/crack-cocaine use. Additionally, cocaine/crack-cocaine use was 
associated with weekly alcohol and marijuana use, having received substance use treatment, and 
elevated rates of psychiatric disorders (Tolou-Shams et al., 2010). When used at levels such that 
a change in behavior or memory loss occurs during use, cocaine has been associated with 
symptoms of depression and somatic and cognitive distress (Castro, Newcomb, & Bentler, 
1988).   
Inhalants. Inhalants are uniquely different from other classes of drugs because they are 
legal for all ages and readily available at home and school, yet their use is difficult to assess 
(Ridenour, Bray, & Cottler, 2007). Inhalants are defined as “volatile substances that produce 
chemical vapors that can be inhaled to induce a psychoactive, or mind-altering, effect” (pg. 1) 
and are often classified into four categories (volatile solvents, aerosols, gases, and nitrites; 
National Institute of Drug Abuse, 2010). Volatile solvents include paint thinner/remover, 
gasoline, glues, and felt tip markers. Home products such as hair sprays and fabric protector 
sprays are classified as aerosols, whereas whipped cream dispensers, butane lighters, propane 
tanks, and refrigerants are classified as gasses (National Institute of Drug Abuse, 2010). Finally, 
nitrites, a somewhat different class of inhalants, dilate blood vessels and relax muscles rather 
than affect the central nervous system, and include cyclohexyl nitrite, isoamyl nitrite, and 
isobutyl nitrite (National Institute of Drug Abuse, 2010). Immediate effects of use include 
psychological changes such as confusion, belligerence, assaultive behavior, apathy, impaired 
judgment and functioning, as well as physiological effects such as dizziness or visual 
disturbances, nystagmus, incoordination, slurred speech, an unsteady gait, and tremors 
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(American Psychiatric Association, 2004). Inhalant use tends to occur frequently among 
adolescents. In fact, between 9.9% and 15.7% of adolescents use inhalants before completing 
high school (Johnston et al., 2009). Current inhalant use rates among these adolescents, however, 
tend to decrease with age (i.e., 4.1% of 8th graders currently use inhalants compared to 1.4% of 
12th graders; Johnston et al., 2009). Additionally, inhalant abuse and dependence has been 
reliably demonstrated to occur among users (Howard, Cottler, Compton, & Ben-Abdallah, 2001). 
A number of negative consequences may occur as a result of inhalant use. Chronic and 
acute physiological effects associated with inhalant use include cardiovascular effects such as 
dysrhythmias, hypoxia-induced heart block, myocardial fibrosis, and sudden sniffing death 
syndrome as well as dermatological and gastrointestinal effects such as burns, contact dermatitis, 
perioral eczema, hepatotoxicity, and nausea or vomiting (Anderson & Loomis, 2003; Brouette & 
Anton, 2001). Additionally, inhalant use is associated with hematologic and neurologic effects 
such as aplastic anemia, bone marrow suppression, leukemia, ataxia, cerebellar degeneration, 
peripheral neuropathy, sensorimotor polyneuropathy and white matter degeneration, as well as 
pulmonary and renal effects (Anderson & Loomis, 2003; Brouette & Anton, 2001). 
Neuropsychiatric effects of inhalant use such as apathy, dementia, depression, insomnia, memory 
loss, poor attention and psychosis may also occur (Anderson & Loomis, 2003; Brouette & 
Anton, 2001).  
Of additional concern among adolescent inhalant users are issues regarding perceived 
risk of danger or possible harmful effects. When considering that perceived rates of peer inhalant 
use are often overestimated by adolescents and that open attitudes toward marijuana and 
inhalants are associated with inhalant use (Crano, Gilbert, Alvaro, & Siegel, 2008), perceived 
risk may play a particularly important role in an individual’s decision to use inhalants. That is, 
                                
 
11 
 
despite a number of acute and chronic negative effects of inhalant use (Fung & Tran, 2006; 
National Institute of Drug Abuse, 2010; Soderberg, 1999), few adolescents perceive inhalant use 
as dangerous. For example, roughly 29% of youth inhalant users believe regular inhalant use to 
be of medium risk of harm, with 4.7% of these adolescents perceiving regular inhalant use as 
having no risk at all (Perron & Howard, 2008). These perceptions are coupled with findings 
demonstrating that only 33.9% of 8th graders and 41.2% of 10th graders consider infrequent use 
of inhalants (i.e., once or twice) to be dangerous (Johnston et al., 2009). As such, the dangers of 
adolescent inhalant use are made clear by the ease of accessibility and relatively low level of 
perceived harmfulness, coupled with an abundance of acute and long-term negative 
consequences. 
Hallucinogens. Many forms of hallucinogens exist and are characterized by a number of 
unpredictable effects. Most commonly, hallucinogens include LSD (acid), mescaline, peyote, 
mushrooms, ecstasy (MDMA), and Salvia (NIDA hallucinogen report; Wu, Ringwalt, Weiss, & 
Blazer, 2009). Both abuse and dependence may result following hallucinogen use (American 
Psychiatric Association, 2004). Hallucinogens are often taken orally and produce hallucinogenic 
effects that often begin with stimulant-like experiences and develop into feelings of euphoria, 
enhanced sensory experiences, and visual, auditory, and tactile hallucinations (American 
Psychiatric Association, 2004; National Institute of Drug Abuse, 2001). However, due to the 
diverse array of substances categorized as hallucinogens, specific hallucinogenic effects differ 
considerably among drugs. For example, LSD often produces vivid emotional and visual 
sensations whereas psilocybin (i.e., the active drug in psychoactive mushrooms) can cause 
difficulties in perception of time and reality (National Institute of Drug Abuse – No. 01-4209, 
2001). Hallucinogen use is fairly common among adolescents. By 12th grade, roughly 8.7% of 
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adolescents have engaged in hallucinogen use. Additionally, 7.8% have used hallucinogens other 
than LSD and 4% have used LSD by 12th grade (Johnston et al., 2009). As would be expected, 
past month inhalant use tends to be lower, with only 0.9% of 8th graders and 2.2% of 12th graders 
endorsing current hallucinogen use (Johnston et al., 2009).  
Hallucinogens are associated with numerous negative psychological consequences and 
disorders. For example, polysubstance use is more common among adolescents who use 
hallucinogens than those who use marijuana (Wu et al., 2009). Additionally, hallucinogen users 
may develop hallucinogen-induced disorders such as hallucinogen persisting perception disorder 
(i.e., flashbacks), hallucinogen intoxication delirium, hallucinogen-induced psychotic disorder 
with delusions or hallucinations, and hallucinogen-induced mood or anxiety disorders (American 
Psychiatric Association, 2004). Differences also have been demonstrated among adolescent 
hallucinogen users compared to marijuana users in MMPI-A Schizophrenia (Sc) and 
Hypochondriasis (Hs) scales (Palmer & Daiss, 2005). In addition to psychological consequences, 
prolonged or permanent changes in cognition may occur following hallucinogen use. For 
instance, cognitive impairments often associated with ecstasy (MDMA) use include deficits in 
recall and working memory, central executive functioning and reasoning, and semantic 
recognition (Montoya, Sorrentino, Lukas, & Price, 2002). Further, salvia use has been implicated 
to cause long-term effects of déjà vu, blunted affect, thought blocking, and slow speech (Singh, 
2007). The wide array of negative consequences associated with hallucinogen use demonstrates 
the importance of developing a strong understanding of this substance among adolescents and 
further serves as rational for identifying additional factors associated with use.  
Methamphetamine. Roughly five million Americans have used methamphetamine at 
least one time (Anglin, Burke, Perrochet, Stamper, & Dawud-Noursi, 2000). Among adolescents, 
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6.8% of 8th graders and 10.5% of 12th graders report using amphetamines (e.g., speed, crystal 
meth, and methamphetamine) before leaving high school. Of these adolescents who endorse 
amphetamine use, 2.8% have used methamphetamine and 2.8% have used crystal meth (Johnston 
et al., 2009). Methamphetamine, classified as a stimulant, increases stimulation of both 
dopamine and norepinephrine receptors in the brain and has a relatively slow rate of 
metabolization compared to cocaine and other stimulants (Anglin et al., 2000). As a result, 
methamphetamine intoxication can last up to 12 hours, often depending on method of 
administration (e.g., smoked, used intravenously, snorted, or ingested orally; Sheridan, Bennett, 
Coggan, Wheeler, & McMillian, 2006). The acute physical effects often associated with 
methamphetamine include decreased appetite; elevated heart rate, blood pressure, and pulse; and 
increased physical activity, respiration, and body temperature (National Institute of Drug Abuse 
– No. 06-4210, 2006). Methamphetamine tends to have an earlier age of first use compared to 
alcohol, marijuana, tobacco, inhalants, hallucinogens, depressants, PCP, and cocaine with a 
slightly earlier age of first use compared to ecstasy, opiates, or crack-cocaine (Brecht, Greenwell, 
& Anglin, 2007). Traditionally concentrated in rural, western and southwestern regions of the 
U.S., methamphetamine use recently has increased nationally, resulting in a growing economic 
burden and increased negative effects on public health (Freese, Obert, Dickow, Cohen, & 
Russell, 2000; Meredith, Jaffe, Ang-Lee, & Saxon, 2005).  
As with other substances, methamphetamine use is often associated with the use of other 
illicit substances (e.g., cocaine, heroin, ecstasy, LSD) and with increased problem behaviors such 
as antisocial behavior, having friends who engage in deviant behaviors, risky sexual behavior, 
being arrested, and selling drugs (Embry, Hankins, Biglan, & Boles, 2009; Herman-Stahl, Krebs, 
Kroutil, & Heller, 2006, 2007). Additionally, adolescents who endorse using methamphetamine 
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at least one time are more likely to participate in high-risk behaviors such as having sexual 
intercourse before age 13, having an increased number of sexual partners, failing to use a 
condom during last intercourse, and using alcohol or drugs before engaging in intercourse 
compared to those who have not used methamphetamine (Springer, Peters, Shegog, White, & 
Kelder, 2007). As a result, methamphetamine use increases risk for contracting hepatitis B and 
HIV and is associated with poorer health conditions (Gorman & Carroll, 2000; Greenwell & 
Brecht, 2003; Vogt et al., 2006). Continued methamphetamine use can have serious long-term 
effects such as anxiety, confusion, insomnia, mood disturbances, paranoia, hallucinations and 
delusions, reduced motor speed, cognitive impairment, and significant structural and functional 
changes in the brain (Kalechstein, Newton, Longshore, Anglin, vanGorp, & Gawin, 2000; 
National Institute of Drug Abuse, 2006). 
Factors Associated with Adolescent Substance Use 
The extensive array of negative consequences associated with adolescent substance use 
highlights the importance of early identification of factors that may play a role in adolescent 
substance use. Elucidating factors commonly associated with adolescent substance use may 
provide valuable information regarding treatment and prevention implications. Traditionally, 
research has focused on non-psychiatric dispositional and environmental factors that may be 
associated with adolescent substance use or the development of a substance use disorder (SUD). 
For example, non-psychiatric dispositional risk factors such as attitudes toward antisocial 
behavior; attitudes toward alcohol, tobacco, and other drugs; low perceived risk of drug use; 
sensation seeking; rebelliousness; and social skill deficits are all associated with adolescent 
substance use (Arthur, Hawkins, Pollard, Catalano, & Baglioni, 2002; Cleveland, Feinberg, 
Bontempo, & Greenberg, 2008).  
                                
 
15 
 
Several environmental and contextual risk factors often associated with negative 
substance use outcomes also have been identified. For example, Durlak (1998) found that drug 
use is commonly associated with community and school variables such as living in an 
impoverished neighborhood, ineffective social policies, and poor quality of schools. 
Additionally, peer- and family-related factors such as negative peer pressure/modeling, peer 
rejection, low socioeconomic status, parental psychopathology, and punitive childrearing have 
been associated with substance use (Durlak, 1998). In a review of research examining risk 
factors that contribute to adolescent substance use, Hawkins, Catalano, and Miller (1992) divided 
risk factors into two categories: broad societal and cultural (contextual) factors and individual 
and interpersonal environments (e.g., family, school, classrooms, and peer groups). Among the 
broad societal and cultural factors, findings indicate that availability of substances, extreme 
economic deprivation, and neighborhood disorganization are associated with adolescent alcohol 
and substance use. Additionally, associations were demonstrated between alcohol and substance 
use and interpersonal factors such as family drug behavior, family management practices, and 
family conflict. Early and persistent problem behaviors, academic failure, peer rejection in 
elementary grades, association with drug-using peers, and favorable attitudes toward drugs were 
also found to be associated with adolescent alcohol and substance use. These non-psychiatric and 
environmental risk factors provide valuable insight into the initiation and maintenance of 
adolescent substance use; however, co-occurring psychopathology likely plays an additional role 
in substance use among youth (Saban & Flisher, 2010).  
Comorbid Psychiatric Disorders and Substance Use  
Psychiatric disorders are common among adolescents, with epidemiological studies 
suggesting that roughly 15-20% of adolescents have a current psychiatric disorder at any given 
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time (Costello et al., 1996; Costello, Mustillo, Erkanli, Keeler, & Angold, 2003; Roberts, 
Roberts, & Xing, 2007). As such, co-occurring (comorbid) psychiatric disorders may play a 
particularly important role in adolescent substance use. That is, comorbid psychiatric disorders 
may differentially contribute the development and maintenance of adolescent substance use 
compared to non-psychiatric dispositional or environmental risk factors (Tate, Brown, Unrod, & 
Ramo, 2004). Indeed, psychiatric disorders co-occur with adolescent substance use at high rates. 
Studies have shown that more than 80% of adolescent high school students with an alcohol use 
disorder exhibit a comorbid psychiatric disorder (Rhode, Lewinsohn, & Seeley, 1996). Further, 
adolescents who display a current SUD are at threefold greater risk for comorbid psychiatric 
disorders such as anxiety, mood, or disruptive behavior disorders compared to adolescents 
without a current SUD (Kandel, et al., 1999).  
Among adolescent substance users, psychiatric disorders have been associated with more 
frequent and severe substance use. For example, in a sample of both addiction treatment 
outpatients and nonclinical adolescents, heavy alcohol use was associated with higher rates of 
mental disorders and psychotic, depression, and anxiety symptoms (Fidalgo, da Silveira, & da 
Silveira, 2008). In a review of studies examining comorbid psychiatric disorders among 
adolescents and youths being treated for SUDs, Couwenbergh et al. (2006) found that between 
61% and 88% experienced comorbid internalizing and externalizing disorders. Further, this study 
found that adolescents and youths with a comorbid psychiatric disorder and SUD exhibited 
higher rates of substance use compared to noncomorbid adolescents (Couwenbergh et al., 2006). 
Given these observed high rates of psychiatric comorbidity among adolescent substance use, an 
examination of underlying psychiatric variables apart from environmental characteristics may 
contribute to our understanding of substance use among adolescents.  
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Comorbid mood and anxiety disorders and substance use. Comorbid mood and 
anxiety disorders may be particularly relevant to examine among adolescent substance use. 
Specifically, early-onset major depression or anxiety disorders may play an important and 
prominent role in the development of adolescent substance use. Evidence suggests that both 
depression and anxiety disorders often begin in the preadolescent and adolescent years of 
development (Burke, Burke, Regier, & Rae, 1990) and thus may serve as risk factors for later 
SUD onset. Additionally, the NIMH Epidemiologic Catchment Area Program study found that 
young adults who had experienced an earlier depressive or anxiety disorder were at twice the risk 
for a subsequent drug use disorder (Christie et al., 1988).  
In a retrospective design examining the onset of depression and its relation to drug abuse, 
drug-dependent patients had an onset of depression as much as 7.2 years earlier than non-drug-
dependent individuals (Abraham & Fava, 1999). In a study conducted by Burke, Burke, and Rae 
(1994) epidemiological data were used to examine the prevalence of co-occurring mood and 
anxiety disorders in relation to onset of drug abuse and dependence. Findings from this study 
suggested that drug use disorders occur at higher rates among individuals who experienced either 
mood or anxiety disorders. This was particularly true when the mood or anxiety disorder had an 
onset during adolescence. Additionally, the onset of a substance use disorder was most likely to 
occur between 15 to 19 years of age if a pre-existing mood or anxiety disorder had occurred. 
These studies suggest that a history of a comorbid psychiatric disorder places one at greater risk 
for subsequent development of a substance use disorder.  
Adolescent substance use and major depressive disorder. Studies have demonstrated a 
relationship between the progression of a SUD and depression symptom severity. In a study 
conducted by Chinet et al. (2006), 102 adolescents between the ages of 14 and 19 years old who 
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met DSM-IV criteria for regular illicit drug or alcohol use were assessed for comorbid 
depression. In examining the progression between depression and substance use over a 3.5-year 
period, a decrease in substance use severity was associated with a decrease in depression and 
depressive symptoms. Groups that remained stable in substance use severity (i.e., high or low 
severity of use) tended to display a constant level of depression (i.e., high or low levels of 
depression). In a longitudinal study examining the relationship between the existence of a major 
depressive disorder (MDD) and SUD, Rao, Hammen, and Poland (2009) assessed the 
development of SUD among adolescents with and without MDD at a two to five year follow-up. 
They found that adolescents with MDD displayed higher rates of SUD development compared to 
their non-depressed counterparts. This study also suggested the existence of a reciprocal 
relationship between MDD and SUD, with substance use preceding the onset of MDD and 
potentially increasing vulnerability to depressive episodes (Rao et al., 2009).  
Adolescent substance use and anxiety disorders. Several studies have demonstrated an 
association between anxiety and adolescent substance use. In a longitudinal study examining 
cigarette smoking and anxiety disorders among adolescents over a period of roughly 8 years, 
cigarette smoking was found to increase risk for the development of several anxiety disorders. 
Specifically, cigarette smoking during adolescence was associated with an increased risk for the 
development of agoraphobia, generalized anxiety disorder (GAD), and panic disorder (PD; 
Johnson, Cohen, Pine, Klein, Kasen, & Brook, 2000). Similar findings among young adults 
suggest that daily cigarette smoking is associated with an increased risk of panic attacks (Breslau 
& Klein, 1999). Further, reviews of current literature examining the co-occurrence of alcohol 
problems and anxiety disorders demonstrate that studies find a close association between 
anxiety-related disorders and problems related to alcohol use (Kushner, Sher, & Beitman, 1990; 
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Kushner, Sher, & Erickson, 1999). Similarly, studies demonstrate that posttraumatic stress 
disorder (PTSD) is associated with an increased risk for alcohol abuse or dependence (Breslau, 
Davis, Peterson, & Schultz, 1997).  
Associations between substance use and anxiety disorders are found also when 
examining simultaneous use of multiple substances. For example, tobacco use and alcohol 
dependence remain significant predictors of anxiety and affective disorders after controlling for 
other drug use (Degenhardt et al., 2001). Although alcohol dependence was associated with 
anxiety, alcohol use or abuse was not associated with increased rates of anxiety disorders. 
Interestingly, alcohol use in the absence of abuse or dependence was associated with lower rates 
of anxiety and affective disorders. In the case of multiple substance use (i.e., tobacco, alcohol, 
and cannabis use in conjunction with sedative, stimulant, or opiate use), cannabis was not 
associated with increased anxiety and affective disorders while the use of tobacco and alcohol 
were associated with these disorders (Degenhardt et al., 2001). Although findings demonstrate 
clear associations between substance use and depression and anxiety, most research has tended to 
focus on the nature of these relationships among clinical samples.  
Mood and anxiety disorders and substance use in clinical samples. As a result of 
these observed high rates of comorbid SU and depression and anxiety, numerous studies have 
examined this relationship exclusively among clinical populations receiving treatment primarily 
for either SU or other psychiatric disorder. For example, Buckstein, Glancy, and Kaminer (1992) 
examined patterns of comorbidity among a sample of 156 adolescent psychiatric inpatients 
between the ages of 13 and 18 years old with a dual diagnosis of SUD and another Axis I or II 
psychiatric diagnosis. They found that 51.3% of adolescent inpatients were diagnosed as having 
a current affective disorder and that 30.7 % were diagnosed with major depression. In order to 
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assess the comorbidity between substance use disorders and anxiety disorders in adolescents, 
Deas-Nesmith, Brady, and Campbell (1998) examined adolescents presenting for comorbid 
substance abuse and psychiatric disorders in an inpatient substance abuse treatment facility, an 
inpatient psychiatric treatment facility, and an outpatient community-based psychiatric treatment 
facility. Thirty-three percent of adolescents in the inpatient adolescent psychiatric unit and the 
community mental health facility, and 67% of those in the substance abuse treatment facility, had 
a co-occurring anxiety disorder and SUD. Additionally, all adolescents who had a co-occurring 
anxiety disorder and SUD reported that the onset of anxiety symptoms preceded the SUD (Deas-
Nesmith et al., 1998).  
Hovens, Cantwell, and Kiriakos (1994) examined comorbid psychiatric disorders among 
52 adolescent inpatient substance abusers and 23 non-substance-abusing adolescent inpatients 
with conduct and/or oppositional defiant disorders. Among the substance-abusing sample, 83% 
had used alcohol, 85% had used cannabis, 40% had used cocaine, 16% had engaged in inhalant 
use, 48% had used hallucinogens, 23% had used amphetamines, and 9% had engaged in opiate 
use. Higher rates of dysthymia, major depression, and social phobia were found among substance 
abusers compared to the non-substance abusers. Further, 85% of adolescent substance abusers 
evidenced co-occurring psychiatric disorders, whereas 65% of non-substance abusers were found 
to display psychiatric disorders (Hovens et al., 1994). As such, a clear relationship exists among 
adolescent substance use and mood and anxiety disorders within clinical populations; however, 
the nature of this relationship among community samples remains equivocal and relatively 
understudied.  
Mechanisms of comorbidity. Though not a focus of the present study, hypotheses 
regarding the mechanisms that underpin relationships between SUDs and depression/anxiety 
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deserve brief mention. High rates of comorbidity between psychopathology (i.e., mood and 
anxiety disorders) and substance use are well established, though the nature of the temporal and 
causal pathways that underlie this relationship remain unclear. Several explanations have been 
proposed. The self-medication hypothesis, initially based on clinical observation, suggests that 
substance use is initiated and maintained in an attempt to assuage or relieve distressing 
psychological symptoms. Specifically, this hypothesis posits that an individual who experiences 
psychopathology is motivated to use substances as an attempt to reduce psychological suffering 
(Khantzian, 1997). A number of studies indirectly support this hypothesis (e.g., Christie et al., 
1988; Rao et al., 2009) by demonstrating that psychopathology often precedes the onset of 
substance use among adolescents.   
 Another hypothesis asserting a directional relationship between psychopathology and 
substance use among adolescents holds that substance use precedes the development of 
psychopathology. This hypothesis suggests that substance use increases the risk for the 
subsequent development of a psychiatric disorder. This notion is supported indirectly by 
arguments that neuroadaptations and neurobiological alterations resulting from prolonged use 
and withdrawal contribute to the development of psychiatric symptoms (McEwen, 2000). 
Because neither directionality hypothesis alone is sufficient to account for all comorbid 
cases, psychopathology and substance use may not be causally related but instead accounted for 
by a third variable. For example, a biological trait or environmental factor such as emotional 
lability or the experience of childhood trauma may increase the risk for the development of 
psychopathology and the onset of substance use. The evidence for a clear relationship between 
psychopathology and substance use is largely equivocal. Possibly these hypothesized 
mechanisms are not mutually exclusive and exist concurrently (Khantzian, 1997). In fact, it is 
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likely that these pathways account for differential contributions toward the development and 
maintenance of both psychopathology and substance use and that a bidirectional relationship 
exists between the occurrence of substance use and comorbid psychiatric disorders. Though this 
project does not focus on elucidating such pathways directly, it does attempt to describe these 
relationships within a population that has historically received very little consideration.  
Limitations of Current Research  
Community based samples. A prominent issue in current research examining comorbid 
psychiatric disorders and adolescent substance use resides in the lack of research examining this 
relationship within community-based samples. That is, studies that have examined the 
association between depression and anxiety and adolescent substance use have been performed 
largely in clinical outpatient or inpatient settings (e.g. Buckstein, et al., 1992; Chinet et al., 2006; 
Deas-Nesmith et al., 1998; Hovens et al., 1994; Libby, Orton, Stover, & Riggs, 2005; Swadi & 
Bobier, 2003). The major existing studies that have examined these comorbidities among 
community samples have been large nationally based surveys (e.g., Johnston et al., 2009; 
SAMHSA, 2009). As a result, two prominent limitations are evident. First, the apparent dearth of 
research exploring this relationship outside of clinical settings limits the generalizability of these 
findings to non-clinical samples (Armstrong & Costello, 2002). Armstrong and Costello (2002) 
underscored the need for research examining this relationship among community populations. 
They noted specific concerns when generalizing findings among clinical samples to 
representative community populations. In particular, adolescents with two or more psychiatric 
disorders are more likely to seek treatment compared to adolescents with only a single 
psychiatric disorder. As a result, an inpatient or clinical sample may display higher rates of 
comorbidity compared to the general population (Armstrong & Costello, 2002). Additionally, 
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some disorders, or combinations of disorders, are more likely to be referred to treatment 
compared to others. For example, an externalizing disorder such as conduct disorder is more 
likely to elicit a referral to treatment compared to internalizing disorders such as anxiety or 
depression. Generalizability may also be limited because temporal ordering and observed risk 
factors may differ between adolescents in a clinical versus community setting (Armstrong & 
Costello, 2002). 
The second limitation pertains to the allocation of community resources and development 
of policies that are not community-specific. National epidemiological studies of adolescent 
substance are those that inform government, education, and health related public policy 
(Johnston et al., 2009), but national data samples may inaccurately reflect local community needs 
for treatment and prevention programs, especially those services intended for minority youth 
(Kip, Peters, & Morrison-Rodriquez, 2002). It has been noted that methods for estimating 
specific community needs for services from national samples, such as synthetic estimation, carry 
certain assumptions that are often violated in actual practice with community samples. In these 
cases, it is more appropriate to directly survey the population in question (Dewit & Rush, 1996). 
As such, this lack of research examining adolescent substance use among community-based 
samples may fail to elucidate unique risk factors that are present (and amenable to intervention) 
in specific communities. 
In an attempt to address these limitations, Costello, Erkanli, Federman, and Angold 
(1999), examined the association between psychiatric disorders and substance use among a 
community sample within a single region of the United States (i.e., southeastern U.S.). In one of 
the few and most widely-cited large-scale community studies on this topic, Costello and 
colleagues found that girls and boys with depression displayed significantly higher rates of 
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lifetime use of any substance compared to those without a psychiatric disorder (88.6% and 
52.2% respectively for girls and 86.5% vs. 50.0% for boys). A similar trend was found in boys 
for smoking (64.5% vs. 11.5%), alcohol use (84.5% vs. 43.0%), cannabis use (57.6% vs. 9.6%), 
and other drug use (48.3% vs. 0.4%) as well as substance abuse or dependence (29.9% vs. 1.5%), 
but not in girls. Interestingly, anxiety was not associated with any type of substance use or abuse 
in either girls or boys (Costello et al., 1999). Although results obtained in the Costello et al. 
(1999) “Great Smoky Mountains Study” provide valuable information into the association 
between psychiatric disorders and adolescent substance use among a specific community 
samples, the lack of a representative minority sample is a significant limitation. The study 
employed a predominantly Caucasian sample with less than 10% African American adolescents 
(Costello et al., 1999). This underrepresentation is significant when considering southern states 
such as Mississippi, a predominantly rural region in which African Americans comprise roughly 
37% of the population (US Census Bureau, 2010). This limitation provides opportunity for future 
research in which patterns of comorbidity between affective disorders and SUDs can be explored 
within a sample more representative of the adolescent population in the southeast.  
Minority samples. Examining variations between adolescent subgroups is an integral 
part in developing a comprehensive understanding of substance use etiology and implementing 
prevention efforts (Johnston et al., 2009). As demonstrated by De La Rosa, Adrados, Kennedy, 
and Millburn (1997) current research remains limited in its understanding of substance use and 
substance using behavior among minority youth. This deficit in understanding is made relevant 
when considering that patterns of drug use likely differ as a function or ethnicity (James & More, 
1997). Additionally, psychological factors may differentially contribute to adolescent substance 
use across race/ethnicity. That is, factors such as sensation seeking, peer substance use, and peer 
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pressure resistance may differentially influence substance use among African American 
adolescents compared to Caucasian adolescents (Brown, Miller, & Clayton et al., 2004). As 
such, research findings examining co-occurring depression and anxiety in adolescent substance 
use among a nonminority sample may not generalize to ethnic minority youth populations. 
To date, several studies have examined the impact of race/ethnicity on adolescent 
substance use (e.g., Fothergill, & Ensminger, 2006; Johnson, 2004; Wang, Matthew, Bellamy, & 
James, 2005); however, these findings remain equivocal. Indeed, disparities are often found 
between minority groups, with mixed findings of substance use rates in minority youth compared 
to White youth (Jackson & LeCroy, 2009; Johnston et al., 2009; SAMHSA, 2009; Wallace & 
Muroff, 2002; Watt, 2004;). With regard to national rates, most data suggest that African 
Americans demonstrate considerably lower rates of current and lifetime licit and illicit drug use 
compared to those of Caucasian and Hispanic ethnicity (Johnston, O’Malley, Bachman, & 
Schulenberg, 2010). For example, national studies suggest that White youth tend to engage in 
twice the rate of current cigarette use and greater than three and a half times the rate of heavy 
alcohol use compared to Black or African American youth (SAMHSA, 2009). Although fairly 
consistent across studies, these rates sometimes differ with regard to age. For instance, African 
American middle school students have shown slightly higher rates of alcohol use compared to 
Caucasians in some samples (45% compared to 37.7%; Jackson & LeCroy, 2009). These 
differences point to the increased need for continued examination of substance use trends among 
both minority and non-minority youth.  
Findings tend to be equally mixed with regard to the contribution of psychosocial 
correlates of substance use across minority youth. A growing body of work has shown that 
psychosocial factors differentially contribute to substance use among minority youth compared 
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to Caucasian youth (e. g., Howard, Walker, Walker, Cottler, & Compton, 1999; Jackson & 
LeCroy, 2009; Watt, 2008). Specifically, African American adolescents may be at elevated risk 
for influence by contextual risk factors such as economic deprivation and higher rates of 
academic difficulties, while Caucasian adolescents may be at increased risk for influence by peer 
use and individual risk factors such as sensation seeking (Wallace & Muroff, 2002). 
Additionally, findings demonstrate that individual, social, and treatment factors differentially 
contribute to substance use treatment attrition among racial subgroups, while cultural factors 
such as perceived discrimination, racial or ethnic identity, or acculturation may not play a 
significant role in treatment attrition (Austin & Wagner, 2010). Specifically, parental alcohol and 
crack-cocaine use is significantly predictive of treatment attrition among African American 
adolescents but not among foreign or native born Hispanic adolescents (Austin & Wagner, 
2010). Conversely, a number of studies have found similarities in risk and protective factors 
across minority and nonminority youth (e.g. peer and family protective factors, coping styles, 
self-esteem, and self-efficacy; Brook, Brook, Arencibia-Mireles, Richter, & Whiteman, 2001; 
Clinton-Sherrod et al., 2005; Roberts & Roberts, 2007). These inconsistent findings highlight the 
need for the continued investigation of risk factors associated with drug-using behavior among 
both minority and nonminority populations, including comparisons of substance use rates and 
psychological correlates of substance use across ethnic groups.  
Rural minority samples. Examining adolescent substance use among a rural sample is 
of additional importance, as underscored by geographical group differences in adolescent 
substance use. Specifically, adolescents in rural areas exhibit substance use rates that consistently 
exceed those found among urban dwelling counterparts. Among 8th graders, those living in 
southern states have consistently demonstrated higher rates of current and lifetime illicit 
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substance use compared to other geographical locations (Johnston et al., 2010). Interestingly, 
these differences do not seem to be as pronounced in older adolescent cohorts (Johnston et al., 
2010). Further, in a secondary examination of the 1999 Monitoring the Future Study, conducted 
by the National Institute on Drug Abuse (NIDA), significantly higher rates of adolescent licit and 
illicit substance use were observed in rural areas compared to other locations in the country 
(National Center on Addiction and Substance Abuse [CASA], 2000). Findings from this study 
showed that 8th graders residing in rural locations were more than twice as likely to smoke 
cigarettes, 29 percent more likely to drink alcohol, 34 percent more likely to use marijuana, 53 
percent more likely to use cocaine, 83 percent more likely to use crack cocaine, and 104 percent 
more likely to use amphetamines than those living in urban areas (CASA, 2000). Rates of use 
continue to be higher among rural 10th graders compared to urban 10th graders in all substance 
categories except Ecstasy and marijuana. Among 12th graders, rural adolescents demonstrated 
higher rates of cigarette, alcohol, cocaine, crack-cocaine, amphetamine, and inhalant use than 
those in urban environments (CASA, 2000). These data confirm that elevated rates of substance 
use (across most substances) are consistently observed among adolescents in rural geographical 
locations.  
Extant studies investigating adolescent substance use among minority populations have 
largely been conducted using urban samples (e.g., Clinton-Sherrod, Sobeck, Abbey, Agius, & 
Terry, 2005; Jackson & LeCroy, 2009). Conversely, studies focusing on adolescent substance 
use among rural populations often utilize a predominantly White sample (e.g., Dunn et al., 2008; 
Hanson et al., 2009; Shears, Edwards, & Stanley, 2006) or have a relatively small sample size 
(Strong, Del Grosso, Burwick, Jethwani, & Ponza, 2005). Consequently, there is a shortage of 
research examining substance use among ethnic minorities in rural settings. This is equally true 
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with regard to associated psychological correlates such as depression and anxiety. As a result, a 
large scale, ethnically diverse and rural-based examination of adolescent substance use and co-
occurring depression and anxiety would contribute considerably to existing literature. 
Aims of Present Study 
Substance use among adolescents is prevalent and associated with an abundance of 
negative consequences. Findings demonstrate a strong relationship between depression and 
anxiety and adolescent substance use in clinical samples. Emerging evidence suggests that a 
similar relationship exists among adolescents in non-clinical populations as well, but few studies 
have examined the relationship between comorbid psychiatric symptoms and substance use 
among ethnically diverse and rural adolescents, the latter of whom appear to be at highest risk of 
SUDs. The following goals and hypotheses are proposed: 
Exploratory Study Goal: Examine epidemiological rates of lifetime adolescent tobacco, alcohol, 
marijuana, cocaine, inhalant, hallucinogen, and methamphetamine use among an ethnically 
diverse community sample in Mississippi. 
 Hypothesis: Given limited extant research examining substance use among community-
based ethnically diverse rural samples, no a priori hypotheses were developed for this study goal. 
Primary Study Goal: Explore the relationship between depression/anxiety and lifetime licit and 
illicit substance use (i.e., tobacco, alcohol, marijuana, cocaine, inhalant, hallucinogen, and 
methamphetamine) among a diverse, rural-based, community sample of adolescents. 
Hypothesis: Depression and anxiety will predict lifetime substance use above and beyond 
relevant demographic and environmental variables (e.g., socio-economic status, grade 
level, race/ethnicity, gender).  
 
                                
 
29 
 
 
 
 
Method 
Participants 
Participants were 5,735 pre-adolescents and adolescents in grades 6 – 12 from several 
counties in Mississippi representing diverse demographic areas. This large number of ethnically 
diverse participants from multiple rural counties in Mississippi provided sufficient power for all 
analyses conducted in the present study. Participants were distributed equally across gender 
(51.4% female). In terms of racial/ethnic background, participants were diverse with a majority 
identifying as either White/Caucasian (n = 3,120, 54.4%) or Black/African American (n = 2,026, 
35.3%). The remaining participants identified as Asian (n = 132, 2.3%), Hispanic (n = 149, 
2.6%), or Other (n = 280, 4.9%). Given the small representation of racial/ethnic backgrounds 
other than White/Caucasian or Black/African American, participants were classified in 
subsequent analyses as White/Caucasian or Other. Given the nature of the study it was not 
feasible to assess annual household income or other socio-economic status (SES) related 
information from adolescents who may not have the ability or knowledge to answer accurately. 
Instead, 2010 U.S. Census data were used as a proxy to provide a general description of annual 
income. Specifically, dummy variables were assigned to county-based median annual income 
and matched to each student by school zone (see Table 1 for description of median annual 
income and population density for counties assessed).  
Measures 
Revised Child Anxiety and Depression Scale (RCADS). The RCADS (Chorpita, 
Moffitt, & Gray, 2005; Chorpita, Yim, Moffitt, Umemoto, & Francis, 2000) is a 47-item self-
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report questionnaire designed to measure childhood anxiety disorders and depression in a 
community, clinical, or research setting. Participants rate how often each item applies to them 
based on a 4-point Likert-type scale (0 = never, 1 = sometimes, 2 = often, 3 = always). Scores 
from the RCADS yield total anxiety and depression scores, a major depressive disorder subscale, 
and 5 anxiety subscale scores: separation anxiety disorder, panic disorder, generalized anxiety 
disorder, social phobia, and obsessive-compulsive disorder. Internal consistency for the RCADS 
scales has been shown to be good (major depressive disorder α = .87, separation anxiety disorder 
α = .78, panic disorder α = .88, generalized anxiety disorder α = .84, social phobia α = .87, and 
obsessive-compulsive disorder α = .82; Chorpita et al., 2005). Confirmatory factor analyses yield 
adequate model fit for the depression factor and all anxiety factors. Factor loadings were 
statistically significant for all RCADS factors with loadings ranging from .53 to .70 for the 
depression factor, .52 to .69 for the separation anxiety disorder factor, .55 to .76 for the panic 
disorder factor, .59 to .79 for the generalized anxiety disorder factor, .51 to .78 for the social 
phobia factor, and .55 to .74 for the obsessive-compulsive disorder factor (Chorpita et al., 2005). 
The RCADS scores demonstrate good convergent validity, with all depression and anxiety scales 
correlated positively and significantly with related and validated assessment measures. 
Specifically, the RCADS major depression scale is significantly and positively correlated with 
the Child Depression Inventory (.70) and the RCADS anxiety scales are each significantly and 
positively correlated with similar scales measured with the Revised Children’s Manifest Anxiety 
Scale (separation anxiety disorder = .60; panic disorder = .64; generalized anxiety disorder = .65; 
social phobia = .72; obsessive-compulsive disorder = .59; Chorpita et al., 2005).  
Modified Youth Risk Behavior Survey (YRBS). The YRBS (Brener et al., 2004) is a 
widely used self-report measure designed to determine the prevalence of health-risk behaviors 
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among young adolescents and high school students. It can be used to assess change over time in 
these behaviors as well as the co-occurrence of health-risk behaviors in six risk areas: 1. 
Behaviors that result in unintentional injuries and violence; 2. Tobacco use; 3. Alcohol and drug 
use; 4. Behaviors that contribute to unintended pregnancy and sexually transmitted diseases; 5. 
Physical inactivity; and 6. Problematic dietary behaviors. Differential response formats and 
scoring techniques are implemented throughout the YRBS in order to address specific study 
aims. Response options vary from a yes/no format to mutually exclusive response choices. 
Scores may be summed or assessed independently for each response. Studies have demonstrated 
test-retest reliability for this measure to be fair, with Kappa values ranging from .24 to .91, with 
a mean of .61 and 93.1% of items demonstrating at least “moderate” reliability (Kappas ≥ .41; 
Brener, Kann, McManus, Kinchen, Sundberg, & Ross, 2002).  
A slightly modified version of the YRBS was used for this study in order to examine 
substance use variables above and beyond those available in the current YRBS. Specifically, 
additional questions were added to assess use of substances not covered in the original YRBS 
(i.e., inhalants other than glue and hallucinogens other than Ecstasy). All additional drug use 
questions were modeled in the same format with regard to question style and response options as 
those currently found in the YRBS. The final version used in this study assessed for the 
occurrence and frequency of both self-reported current (past 30 days) and lifetime use of 
tobacco, alcohol, marijuana, cocaine, inhalants, hallucinogens, and methamphetamine. For 
current use, response choices (i.e., 0 days, 1-9 days, 10-19 days, 20-29 days, and 30 days) denote 
the number of days of use within the past 30 days. Lifetime substance use for each substance 
employed a yes/no response format and was assessed dichotomously (e.g., “Have you ever used 
alcohol?”). Responses included in results for the current study used only those examining 
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lifetime use and employed a dichotomous yes/no format. Items used in the current study have 
previously demonstrated good Kappa reliability: 85.7% for lifetime tobacco use, 81.9% for 
lifetime alcohol use, 89.8% for lifetime marijuana use, 73.4% for lifetime cocaine use, 67.0% for 
lifetime inhalant use, and 70.7% for lifetime methamphetamine use (note, Kappa reliability was 
not observed for hallucinogen use; Brener et al., 2002).  
Demographic Questionnaire. Participants also completed a demographic questionnaire 
inquiring about their age, gender, and racial/ethnic identity.  
Procedure 
Procedures for this study were approved by the University of Mississippi’s Institutional 
Review Board. Participants were recruited as part of the Behavioral Vital Signs Screening (BVS) 
project, which is an ongoing mental health screening program administered to public schools in 
Mississippi. It was offered free of charge to every public school in the state of Mississippi from 
August 2008 to present. Following the provision of passive informed consent (i.e., all 
adolescents in this study were provided with informed parental assent documents that were 
returned only upon declining participation), participants completed a questionnaire packet 
including the measures described above. Participants were instructed that their involvement in 
the study was voluntary, that their responses were anonymous and confidential, and that 
participation would in no way influence their academic standing or educational status.  
Data from questionnaires were collected from each school in a single administration, with 
collection dates and logistic preparations coordinated with school personnel prior to 
administration. Students were administered the RCADS, YRBS, and demographic questionnaire 
in packet form during normal class time. They recorded their answers on computer-scored 
response sheets (SCANTRON®). Students completed questionnaires during class time; teachers 
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aided in administration. Both teachers and research staff were available throughout the 
administration process to read questions aloud and help in proper responding for participants 
who had trouble reading or understanding questions.  
Statistical Analyses 
Consistent with the exploratory goal of the study, descriptive statistics were calculated to 
examine lifetime substance use rates by grade. Next, in order to address the primary study goal, a 
preliminary multivariate analysis of variance (MANOVA) was conducted to identify 
demographic variables to be entered as covariates for subsequent analyses. In order to determine 
the extent to which relevant sociodemographic variables, depression, and anxiety reliably 
predicted lifetime use of tobacco, alcohol, marijuana, cocaine, inhalants, hallucinogens, and 
methamphetamine, a multivariate logistic regression analysis was conducted in which all 
predictor variables were entered simultaneously. Follow-up univariate hierarchical logistic 
regressions were conducted in order to examine the extent to which depression and anxiety 
predicted lifetime use for individual substances above and beyond relevant sociodemographic 
covariates. Specifically, relevant sociodemographic variables, identified from the preliminary 
MANOVA, were entered as covariates in the first step of the model, followed by depression and 
subscale scores of anxiety in the second step; this format was repeated for each substance of 
interest. In all analyses, depression was expressed as a single variable, while anxiety was 
expressed as five separate subscale variables (separation anxiety disorder, panic disorder, 
generalized anxiety disorder, social phobia, and obsessive-compulsive disorder). Data were 
analyzed using PASW by SPSS version 17.0.  
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Results 
Preliminary Analyses 
Prior to conducting analyses, predictor (demographic variables, depression, anxiety) and 
criterion (lifetime use of tobacco, alcohol, marijuana, cocaine, inhalants, hallucinogens, and 
methamphetamine) variables were screened for accuracy of data entry and violations of 
assumptions). Histograms and scatter plots were used to examine assumptions of normal 
distribution, linearity, homoscedasticity and homogeneity. In order to assess for multivariate 
outliers, a Mahalanobis test was conducted and scores that exceeded a predetermined chi-square 
cutoff (p < .001) were excluded from analyses. As a result, 104 participants were identified as 
multivariate outliers (1.8 % of entire sample) and thus excluded from further analyses. 
Exploratory Analyses: Rates of Lifetime Substance Use 
Consistent with the exploratory study goal, prevalence of lifetime substance use across 
grade levels and substances are presented in Figure 1 and Table 2. Overall use of any illicit 
substance by 8th grade was 22.7%. This rate increased to 50.1% by 12th grade.  Of particular 
interest are findings that suggest a differential trend in lifetime use from 6th to 12th grade with 
reference to specific substance of use. For example, lifetime smoking and alcohol use rates from 
6th to 12th grade displayed an increasing linear trend from 10.2% to 44.5% and from 23.2% to 
72.0% respectively. As a result, lifetime tobacco use for 12th graders was 4.4 times greater than 
for 6th graders; lifetime alcohol use was 3.1 times greater among high school seniors compared to 
6th graders. Marijuana use displayed a similar yet slightly steeper increasing linear trend from 
7.8% in 6th grade to 39.2% in 12th grade. This trend represents an overall increase in which 
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roughly 5 times the number of 12th graders report having engaged in marijuana use compared to 
6th graders.  
Cocaine and inhalant use displayed a considerably flatter linear trend compared to those 
observed in tobacco, alcohol, and marijuana lifetime use. Specifically, rates of lifetime cocaine 
use were endorsed at a much more consistent rate when comparing 6th graders to 12th graders 
(6.7% to 11.1%). As such, rates of lifetime cocaine use among 12th graders were only 1.7 times 
greater than those observed among 6th graders. Further, lifetime inhalant use increased from 
12.2% in 6th graders to 17.9% in 12th graders, demonstrating 12th grade lifetime use to be only 
1.5 times higher than lifetime use endorsed by 6th graders.  
Increase in hallucinogen and methamphetamine lifetime use tended to be more moderate. 
Specifically, hallucinogen use among 12th graders was 2.7 times greater than 6th graders (12.1% 
compared to 4.4% respectively). Similarly, lifetime methamphetamine use increased from 3.0% 
in 6th graders to 6.3% in 12th graders, a trend representing a moderate increase in which 12th 
grade lifetime methamphetamine use was 2.7 times greater than 6th grade. 
Primary Analyses: Relationships between Depression/Anxiety and Substance Use 
Preliminary associations. In order to identify relevant sociodemographic variables to be 
use in subsequent regression analyses, a MANOVA was conducted with seven dependent 
variables (lifetime use of tobacco, alcohol, marijuana, cocaine, inhalants, hallucinogens, and 
methamphetamine). Demographic variables of interest representing independent variables were 
SES, grade level, ethnicity, and gender. Using Wilks’ criteria, the combined DVs were 
significantly affected by SES, F (35, 22789) = 1.598, p = .014, gender, F (7, 5417) = 6.543, p < 
.001, and grade level, F (42, 25411) = 6.908, p < .001, but not by race/ethnicity, F (7, 5417) = 
1.371, p = .213. Although race/ethnicity was not identified as a significant potential covariate, it 
                                
 
36 
 
was retained in subsequent analyses in order to remain consistent with study aims and theoretical 
rationale.   
 In the initial multivariate logistic regression analysis, sociodemographic variables (SES, 
grade level, ethnicity, and gender) and primary predictor variables (depression, separation 
anxiety disorder, panic disorder, generalized anxiety disorder, social phobia, and obsessive-
compulsive disorder) were entered simultaneously to predict lifetime tobacco, alcohol, 
marijuana, cocaine, inhalant, hallucinogen, and methamphetamine use. Using Wilks’ criteria, the 
overall model examining the combined criterion variables was significant, F (70, 32054) = 
22.793, p < .001. Further, the model was significant in predicting lifetime tobacco, F (10, 5502) 
= 65.182, p < .001, alcohol, F (10, 5502) = 88.363, p < .001, marijuana, F (10, 5502) = 60.122, p 
< .001, cocaine, F (10, 5502) = 11.228, p < .001, inhalant, F (10, 5502) = 27.439, p < .001, 
hallucinogen, F (10, 5502) = 22.901, p < .001, and methamphetamine use, F (10, 5502) = 
15.648, p < .001. These findings provided support for subsequent examination of each substance 
individually.  
Depression and anxiety as incremental predictors of alcohol and tobacco use. To 
identify the unique contributions of the sociodemographic variables versus affective variables for 
each substance, a series of hierarchical logistic regressions were performed as articulated above. 
That is, seven separate hierarchical logistic regression analyses were conducted, each examining 
lifetime use of a single substance as the criterion variable. In the first step of the regression 
examining lifetime tobacco use, sociodemographic variables significantly predicted lifetime 
tobacco use, χ2 (4, n = 5,666) = 331.57, p < .001, and correctly classified 98.5% of non-lifetime 
users and 3.8% of users. In the second step, depression and anxiety dimensions significantly 
improved the model, χ2 (6, n = 5,666) = 260.16, p < .001, and correctly classified an additional 
                                
 
37 
 
11.2% of lifetime tobacco users. The overall model was significant, χ2 (10, n = 5,666) = 591.73, 
p < .001, and correctly classified 95.9% of non-lifetime tobacco users and 15% of lifetime 
tobacco users, for an overall correct classification of 64.8% (Table 4).  
 For alcohol use, in the first step of the model, sociodemographic variables significantly 
predicted lifetime alcohol use, χ2 (4, n = 5,626) = 608.11, p < .001, and correctly classified 
82.0% of non-users and 44.2% lifetime users. The second step of the model was significant, χ2 
(6, n = 5,626) = 209.23, p < .001, and the inclusion of depression and anxiety dimensions 
correctly classified an additional 9.6% of lifetime alcohol users. The overall model significantly 
predicted lifetime alcohol use, χ2 (10, n = 5,626) = 817.34, p < .001, and correctly classified 
77.3% of non-users and 53.8% of lifetime users for an overall correct classification of 66.6% 
(Table 5).   
Depression and anxiety as incremental predictors of illicit substance use. With regard 
to marijuana use, sociodemographic variables were significant in predicting lifetime marijuana 
use, χ2 (4, n = 5,609) = 386.20, p < .001, and correctly classified 99.6% of non-users and 2% of 
lifetime users. In the second step, depression and anxiety dimensions significantly improved the 
model, χ2 (6, n = 5,609) = 162.16, p < .001, and classified an additional 5.8% of lifetime 
marijuana users. The overall model was significant, χ2 (10, n = 5,609) = 548.36, p < .001, and 
correctly classified 98.4% of non-users and 7.8% of lifetime marijuana users for an overall 
correct classification of 80.5%. It should be noted that although statistically significant, the 
model tended to over-classify individuals as non-users and under-classify lifetime marijuana 
users (Table 6).  
 For cocaine use, sociodemographic variables significantly predicted lifetime cocaine use, 
χ
2
 (4, n = 5,599) = 34.11, p < .001. However, this step failed to correctly classify any individuals 
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who reported lifetime cocaine use. Rather, a significant model was achieved by classifying all 
individuals as non-users. The addition of depression and anxiety dimensions was significant as 
well, χ2 (6, n = 5,599) = 73.28, p < .001, but equally failed to correctly classify any lifetime 
cocaine users. As such, the overall model, although significant, χ2 (10, n = 5,599) = 107.38, p < 
.001, classified all individuals as non-users and failed to correctly classify any individuals who 
reported lifetime cocaine use (Table 7).  
 Similar results to those demonstrated for lifetime cocaine use, were observed in inhalant, 
hallucinogen, and methamphetamine use (see Tables 8 though 10).  In all cases, the overall 
models were significant in predicting inhalant use, χ2 (10, n = 5,579) = 244.52, p < .001, 
hallucinogen use, χ2 (10, n = 5,568) = 211.81, p < .001, and methamphetamine use, χ2 (10, n = 
5,556) = 141.55, p < .001. However, the overall model for inhalant use was only able to correctly 
classify 1.7% of lifetime inhalant users, the overall model for hallucinogen use was limited to a 
correct classification of only .5% of lifetime users, and the overall model for methamphetamine 
use was unsuccessful in classifying any lifetime methamphetamine users.  As such, these cases 
demonstrate statistical significance but fail to achieve models that adequately differentiate 
individuals with no history of use from those who report lifetime use.  
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Discussion 
Utilizing a large representative sample, the present study obtained epidemiological rates 
of adolescent tobacco, alcohol, marijuana, cocaine, inhalant, hallucinogen, and 
methamphetamine use across grade levels among a diverse, rural-based, community sample of 
adolescents. The present study additionally, and primarily, explored the relationship between 
depression and anxiety and licit (i.e., tobacco and alcohol) and illicit substance use (i.e., 
marijuana, cocaine, inhalant, hallucinogen, and methamphetamine) among these adolescents. 
Specifically, this study examined the role of depression and anxiety in predicting licit and illicit 
substance use above and beyond relevant sociodemographic covariates within this unique 
community sample. 
Prevalence Rates of Substance Use Compared to Extant Findings 
Overall, lifetime substance use among Mississippi adolescents tended to vary 
considerably across substances when compared to national rates of use. When considering licit 
substance use, Mississippi adolescents tended to report lower rates of tobacco and alcohol use 
across almost all grade levels than those observed in two national surveys conducted by the 
Center for Disease Control and Prevention (CDC; CDC, 2010; Shanklin, Brener, McManus, 
Kinchen, & Kann, 2007). For example, while roughly 45% of Mississippi youth reported 
engaging in lifetime tobacco use by 12th grade, the CDC found that 55.5% reported lifetime use 
nationally. Similarly, Mississippi youth reported lower rates of lifetime alcohol use compared to 
those observed nationally, with roughly 72% of 12th graders reporting lifetime use in Mississippi 
compared to 79.7% nationally (CDC, 2010). These trends are interesting considering that rural 
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adolescents at all age groups are more likely to smoke cigarettes and use alcohol than 
adolescents residing in large urban areas (CASA, 2000). It is possible that Mississippi, in 
contrast to other similar rural states, has devoted particular resources to tobacco and alcohol 
prevention that helps account for this discrepancy. For example, in the 2011 fiscal year, 
Mississippi spent $9.9 million on tobacco prevention. Although this amount was only 25.3% of 
the CDC’s recommendation for spending, it was considerably higher than neighboring states 
such as Alabama, which met only 1.5% of CDC’s recommended spending (i.e., $860,000) and 
Tennessee, which allocated finances totaling 0.3% of the CDC’s recommended spending 
($200,000; Campaign for tobacco free kids, 2011). As a result, it is possible that initial 
prevention efforts in Mississippi have helped to lower licit substance use rates among 
adolescents in this sample.  
When compared to national rates, lifetime marijuana use tended to demonstrate 
somewhat different results to those observed for licit substances. That is, lifetime marijuana use 
among Mississippi adolescents was higher in early middle school youth but lower among late 
high school adolescents when compared to nationally reported rates. For example, while 3.7%-
5.5% of 6th graders nationally reported lifetime use of marijuana, 7.9% of 6th graders in 
Mississippi reported lifetime marijuana use (Shanklin et al., 2007). These trends were reversed 
among high school youth with 45.6% reporting lifetime marijuana use nationally and only 39.2% 
of 12th graders reporting lifetime marijuana use in Mississippi (CDC, 2010).  
In a manner quite different to that observed for tobacco and alcohol use, Mississippi 
youth reported generally higher rates of lifetime, cocaine, inhalant, hallucinogen, and 
methamphetamine use compared to those observed in comparative national surveys (i.e., CDC, 
2010; Johnston et al., 2009; Shanklin et al., 2007). With regard to cocaine and inhalant use, both 
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Mississippi middle school and high school youth reported lifetime rates equal to or greater than 
national rates at every grade level. For example, by 12th grade, Mississippi youth demonstrated 
considerably higher rates of lifetime cocaine and inhalant use (11.1% compared to 7.9% 
nationally for cocaine and 17.9% compared to 9.1% nationally for inhalants). Mississippi 
adolescents reported higher rates of hallucinogen use in both 8th and 12th grade (8.7% and 12.1% 
respectively) compared to national rates (3.3% and 8.7%). Similar trends were observed in 
methamphetamine use with roughly 8% of 8th graders and 6.3% of 12th graders using 
methamphetamine in Mississippi compared to only 2.3% of 8th graders and 2.8% of 12th graders 
nationally (Johnston et al., 2009).  
Of additional interest are the differential linear trends of increasing use observed among 
this sample. Specifically, changes in rates of use tended to vary considerably by substance. This 
is particularly true with regard to cocaine and inhalant use compared to tobacco, alcohol, and 
marijuana use. Specifically, the linear trends for cocaine and inhalant use were considerably 
flatter than those for tobacco, alcohol, and marijuana use. Further, as mentioned previously, 
Mississippi youth demonstrated considerably higher rates of lifetime cocaine and inhalant use 
compared to those nationally at all grade levels. Such trends suggest that fewer Mississippi youth 
initiate use of these substances later on in adolescence as compared to later initiation of tobacco, 
alcohol, and marijuana. These findings call attention to the particularly problematic nature of 
early initiation of cocaine and inhalant use and highlight the need for early intervention and 
prevention efforts.  
Overall, findings from the present study indicate that Mississippi youth generally engage 
in lower rates of lifetime tobacco and alcohol use compared to those observed nationally; 
however, these trends do not extend to illicit drug use. By 12th grade, Mississippi youth report 
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higher rates of lifetime use across all illicit substances other than marijuana in comparison to 
youth nationally.  
Depression and Anxiety as Predictors of Adolescent Substance Use  
The primary goal of the current study was to examine the role of depression and anxiety 
among a diverse, rural-based, community sample of adolescents, a population at heightened risk 
for adolescent substance use. As predicted, lifetime licit and illicit substance use was 
significantly associated with current symptoms of depression and anxiety. Further, relevant 
demographic and environmental variables (SES, gender, ethnicity, and grade level), depression, 
and anxiety were statistically significant in differentiating those who had engaged in lifetime 
substance use from those who had not. This was particularly true of tobacco and alcohol use. It 
should be noted, that although statistically significant, overall models were not particularly 
accurate in classifying lifetime users of most illicit substances.  
When considering the distinct role of sociodemographic variables in predicting lifetime 
use for specific substances, the findings tended to vary considerably across variables. As was 
expected, grade significantly predicted lifetime use across all substances. That is, youth in higher 
grade levels were significantly more likely to have used both licit and illicit substances compared 
to younger adolescents. Conversely, race did not significantly predict lifetime use for any 
substance other than methamphetamine, in which non-White individuals were more likely to use 
than White adolescents. With regard to SES and gender, findings varied considerably across 
substances. For instance, although neither SES nor gender were significant predictors of lifetime 
tobacco use, both significantly predicted lifetime alcohol and marijuana use. Specifically, being 
male predicted higher rates of both alcohol and marijuana use while low SES was associated 
with lifetime alcohol use and high SES was associated with marijuana use.  
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With regard to the role of depression and specific anxiety dimensions predicting 
substance use beyond sociodemographic variables, findings were generally mixed. Further, 
although statistically significant, the observed odds ratios for all depression and anxiety variables 
suggest generally modest influences on lifetime substance use. The presence of depression 
incrementally predicted lifetime use for all substances examined; however, findings suggest that 
individuals who display depression symptoms are only at a moderately higher risk to have 
engaged in lifetime substance use compared to non-depressed counterparts. When considering 
specific anxiety dimensions, findings tended to be mixed and vary considerably across disorders. 
For example, panic disorder emerged as the only consistent and most influential predictor of 
adolescent substance use. Generalized anxiety disorder symptoms were indicative of an 
increased likelihood of lifetime tobacco and alcohol use. Interestingly, in contrast to panic 
disorder and generalized anxiety disorder, several anxiety dimensions emerged as factors 
associated with a lower likelihood of substance use. For example, adolescents who reported 
elevated social phobia symptoms demonstrated a lower likelihood of use for all substances 
examined. Although both subclinical and clinical social phobia is commonly associated with a 
higher likelihood of substance use among adults (e.g., Crum & Pratt, 2001), it is possible that the 
experience of social phobia among adolescents in this sample may limit exposure to substance 
use and substance-using peers and ultimately decrease likelihood of use.  
In contrast to those variables that demonstrated a consistent trend across substances, 
separation anxiety disorder displayed an oscillating influence. For example, the experience of 
separation anxiety disorder symptoms was associated with a lower likelihood of lifetime use for 
tobacco, alcohol, and inhalants; however, it was alternatively associated with a higher likelihood 
of use for lifetime use of cocaine, hallucinogens, and methamphetamine. Again, for all anxiety 
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disorder dimensions, corresponding odds ratios suggest a limited and modest role. As such, 
findings must be interpreted cautiously.  
It should be noted however, that although modest odds ratios were obtained for each 
individual disorder, it is likely that both the experience of depression and anxiety dimensions, 
specifically panic disorder and generalized anxiety disorder, play at least a small role in the 
experience of lifetime substance use among adolescents in this diverse community sample. 
Further, the mixed findings between anxiety dimensions on particular substances may call 
attention to the differential role of specific anxiety subtypes among different substances. When 
considering the performance of the overall models, depression and anxiety added most to the 
incremental prediction of lifetime tobacco and alcohol use. Conversely, although statistically 
significant, models including depressive and anxiety symptoms were generally unsuccessful in 
differentiating users from non-users for illicit substances, primarily because they assisted little in 
the identification of users. Specifically, the overall model predicting lifetime marijuana use 
demonstrated minimal success, while models for cocaine, inhalants, hallucinogens, and 
methamphetamine were able to predict only an inconsequential percent of lifetime users. It is 
possible however, that the models were unsuccessful in predicting lifetime use for the illicit 
substances examined in this study due to low base rates in which best fit models and statistical 
significance were achieved by classifying all adolescents as non-users. Overall, models were 
moderately successful in predicting lifetime tobacco and alcohol use, yet unsuccessful in 
predicting lifetime illicit substance use.  
In total, findings demonstrate the statistically significant role of comorbid depression and 
anxiety in predicting adolescent licit substance use (i.e., tobacco and alcohol) with some limited 
evidence for the modest role of comorbid depression and anxiety in illicit substance use. 
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Depression and anxiety dimensions were generally statistically significant in predicting lifetime 
use but differed slightly from findings observed by Costello et al., (1999). Specifically, similar to 
Costello et al., (1999), depression emerged as a generally consistent predictor of adolescent use, 
a relationship that was particularly true among males. In contrast, while anxiety dimensions (i.e., 
panic disorder and generalized anxiety disorder in particular) predicted lifetime use among the 
current sample, Costello et al., (1999) found no relationship. It should be noted that although 
similar (i.e., community-based), the sample included in the current study was considerably more 
ethnically diverse than the sample examined by Costello et al. (1999). As such, findings 
demonstrate the potentially differential impact of depression and anxiety among this diverse 
sample compared to other community samples and suggests a modest role in the likelihood of 
use for most licit and illicit substances. 
Extension of Findings to Mississippi Adolescents 
The present findings contribute to current research in a number or ways. First, although a 
fairly consistent relationship exists between psychological variables such as depression and 
anxiety and substance use within clinical settings, limited research has been conducted to extend 
these findings to community populations. As noted by Armstrong and Costello (2002), it is 
inappropriate to generalize findings from clinical samples to community populations. As such, 
this study provides support for the role of depression and anxiety in adolescent substance use 
among this non-clinical community sample. In doing so, findings highlight community needs in 
a manner that may help to inform local policy, treatment, and prevention programs. It should be 
noted, however, that the small effect sizes observed in the current study suggest a relatively 
modest impact of depression and anxiety among this community sample compared to more 
clinical populations. Indeed, Costello et al., (1999) found adolescent substance use to be 
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associated with depression but not anxiety among a similar community sample. As such, it is 
likely that these psychological factors, although important within this community sample, 
contribute to a greater extent to adolescent substance use among clinical populations. As a result, 
it is possible that environmental and contextual factors such as family, peer, school, and 
community influences play a stronger role in substance use within this population than do 
depression and anxiety.  
Second, geographical group differences are often observed in adolescent substance use. 
Indeed, results from several national studies indicate that rates of adolescent licit and illicit 
substance use often differ by geographical location and are generally highest in rural areas 
(National Center on Addiction and Substance Abuse [CASA], 2000; Lambert et al., 2008; Strong 
et al., 2005). Further, studies have suggested higher rates of illicit substance use among 
adolescents residing in southern states (Johnston, O'Malley, Bachman, & Schulenberg 2010). 
To date, no studies have examined comorbid depression and anxiety among adolescents residing 
in Mississippi, both a predominantly rural and southern state. Given this, the current study 
extends the association between depression and anxiety and adolescent substance use to an 
understudied population at risk for elevated rates of substance use.  
Third, there is a shortage of research examining adolescent substance use among ethnic 
minorities residing in rural settings (De La Rosa et al., 1997). This is particularly true with 
regard to research examining associated psychological factors that may contribute to adolescent 
substance use, such as comorbid depression and anxiety. Although the current study did not 
specifically examine racial/ethnic group differences in depression and anxiety, this study 
employed a large minority sample in which roughly half of the participants were African 
American or another minority. Findings thus provide indirect support for the roles of comorbid 
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depression and anxiety and adolescent substance use among a historically underrepresented 
population (i.e., ethnically diverse participants of predominantly low SES and residing primarily 
in rural geographical locations). 
Implications for Current Prevention Programs in Rural Communities 
 Although depression and anxiety differ in magnitude and by disorder in their role in 
adolescent licit and illicit substance use, this study and others (e.g., Burke et al., 1994; Chinet et 
al., 2006; Christie et al., 1988) consistently highlight associations between adolescent substance 
use and depression and anxiety. By its extension to an understudied population, this study 
highlights the need for psychologically-based mental health and substance use prevention efforts 
in rural and impoverished areas. This may be particularly true for rural areas that consist of an 
ethnically diverse population. Indeed, racial/ethnic differences in perceived harmfulness of licit 
and illicit substances may exist in rural settings (Stern, & Wiens, 2009) and have the potential to 
differentially influence rural prevention programs. 
The rural environment may present additional challenges to adolescent health in which 
rural youth are at an increased risk for an array of negative health outcomes (Cherry, Huggins, & 
Gilmore, 2007). Rural adolescents additionally demonstrate a number of negative health 
behaviors and may be at particular risk for mental health problems and substance use (Curtis, 
Waters, & Brinds, 2011). Unfortunately, rural and ethnically diverse communities present a set 
of unique challenges to implementing prevention research and programs. That is, the rural 
environment may not have the resources necessary for effective delivery of substance abuse 
prevention or treatment programs. Additionally, rural areas may provide fewer opportunities for 
adolescents to minimize substance use risk such as changing schools or avoiding disruptive 
environments (Scaramella & Keyes, 2001). As a result, rural-based prevention efforts should 
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address the environmental characteristics unique to rural settings. Equally, evidence-based 
substance use prevention programs that have been tested in non-rural settings should be 
evaluated for their adaptability to rural areas (Smith & Caldwell, 2007). 
 To date, a number of substance use prevention programs have been designed specifically 
for implementation in rural communities. These programs have sought to address both early risk 
factors as well as preventative intervention strategies. For example, an early intervention 
program targeted toward the prevention of substance use risk factors in preschool children 
demonstrated efficacy in improving caregiver involvement and social competence among rural 
children and families (Kaminski, Stormshak, Good, & Goodman, 2002). Substance use 
prevention strategies among rural school age youth have also demonstrated some effectiveness. 
For example, Trudeau, Spoth, Lillehoj, Redmond, and Wickrama (2003) demonstrated that a 
school-based intervention significantly slowed the rate of increase in alcohol, tobacco, and 
marijuana initiation. Additionally, this program slowed the rate of decrease in refusal intentions 
and negative outcome expectancies among a sample of rural seventh graders. Further, in a 
prevention approach aimed at school-based comprehensive education and case-management, 
Zavela et al. (1997) demonstrated effectiveness in improving academic achievement and 
reducing current use of alcohol and other drugs in a rural, at-risk population.  
Although several prevention efforts have been established specifically for youth in rural-
based communities, few have addressed psychological risk factors that may contribute to the 
development and maintenance of adolescent substance use among these populations. Indeed, an 
effective prevention program should minimize both maladjustment and clinical dysfunction (e.g., 
depression and anxiety) in adolescents (Kazdin, 1993). Further, prevention and treatment efforts 
may be enhanced by addressing comorbid psychological disorders (Merikangas & Avenevoli, 
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2000). For example, in a randomized clinical trial of adolescents with comorbid bipolar disorder 
and alcohol abuse or dependence, Geller et al. (1998) demonstrated that lithium was effective in 
reducing symptoms of both depression and alcoholism. Further research on prevention and 
treatment efforts among this adolescent population should focus on regular screening for 
depression and anxiety symptoms, prevention efforts for at-risk youth, evaluation and 
incorporation of interventions targeting these symptoms, and assessment of feasibility and 
accessibility of delivery of such services. This may be particularly true for tobacco and alcohol 
prevention and treatment efforts within these communities. In doing so, it may be possible to 
enhance adolescent substance use prevention and treatment in diverse rural communities such as 
Mississippi.  
Conclusion: Strengths, Limitations and Future Directions 
Several noteworthy strengths exist within the current study. Namely, this study utilized a 
very large sample of adolescents, representative of a number of geographic areas across 
Mississippi. As noted earlier, the sample included in this study was ethnically diverse and unique 
in a number of sociodemographic variables, particularly those related to low SES and rural 
geographical regions. Further, this study employed a passive consent format in which over 99% 
of potentially eligible individuals participated in the study, allowing for an accurate 
representation of sampled locations.  
Despite considerable strengths within this study, a number of limitations should be 
highlighted. First and foremost, data were cross-sectional and thus we are unable to infer 
directionality of findings. We are unable to conclude whether depression and anxiety contribute 
to the onset or maintenance of adolescent substance use, whether adolescent substance use 
contributes to the experience of depression and anxiety, or if a third variable exists that may 
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account for both depression and anxiety and adolescent substance use. Second, data included in 
this study were self-report and may not be as reliable as interview-based methods. However, the 
RCADS has demonstrated both convergent and discriminant validity consistent with well 
validated interview-based assessment measures (Chorpita et al., 2005). Nevertheless, future 
studies should utilize longitudinal and interview-based methods to examine the role of 
depression and anxiety in substance use over time among similar populations. Third, the current 
study did not examine possible interactions between variables of interest and adolescent 
substance use. For example, it is possible that an interaction between SES and gender 
significantly contributed to adolescent substance use in which low SES played a significant role 
in substance use for males but not females. Statistical analyses conducted in this study did not 
examine moderating variables and may have failed to identify contributing interactions to 
lifetime use. Further, this study did not include population density variables in statistical analyses 
and are thus unable to make definitive statements about the relative role of rural/low SES versus 
urban/higher SES living conditions. However, as a whole, Mississippi has a predominantly rural 
geographic landscape and is the poorest state in the country with roughly 21.3% of individuals 
living in poverty, a rate that is significantly higher than any other state in the country and nearly 
two times higher than the national poverty rate (US Census Bureau, 2010). Indeed, more than 
half (53.8%) of participants in the current study were drawn from counties with fewer than 
50,000 residents, and over 40% of participants resided in counties with a median income less 
than $30,000 annually. Finally, it should be noted that this study utilized current rates of 
depression and anxiety to predict lifetime rates of substance use. Given that the experience of 
lifetime substance use may be temporally removed from the experience of current depression and 
anxiety, findings may not accurately reflect a direct relationship between variables. Future 
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studies should extend findings by examining current depression and anxiety disorders in the 
prediction of current substance use.    
Overall, findings demonstrate the significant role of depression and anxiety disorders, 
specifically panic disorder and generalized anxiety disorder, above and beyond relevant 
sociodemographic variables (SES, gender, ethnicity, and grade level) in predicting lifetime 
substance use among this unique population. Although the magnitude of impact tended to vary 
depending on type of substance and in many cases was associated with relatively small increases 
in risk, findings provide evidence for the important role of psychological correlates such as 
depression and anxiety in substance use among Mississippi adolescents. This is particularly true 
with regard to tobacco and alcohol use. Findings extend previous research and suggest the need 
to explore early substance use prevention initiatives that incorporate components aimed at 
preventing and treating depression and anxiety. 
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Table 1.  
 
Median annual income and population density for counties assessed 
 
 
 County 
 
n 
 
Income 
 
Population 
 
 
Bolivar 
 
Coahoma 
 
Hancock 
 
Hinds 
 
Jackson 
 
Jefferson 
 
Madison 
 
 
1,547 
 
558 
 
859 
 
391 
 
2,393 
 
723 
 
384 
 
$28,779 
 
$28,320 
 
$43,491 
 
$38,826 
 
$51,034 
 
$24,352 
 
$62,129  
 
34,145 
 
26,151 
 
43,929 
 
245,285 
 
139,668 
 
7,726 
 
95,203 
 
 
Note. Income and population density data were retrieved from the 2010 U.S Census. 
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Table 2 
 
Lifetime Substance Use for Adolescents in Grades 6 through 12 
 
 
Grade 
(n) 
  
 
6 
(1172) 
 
7 
(1485) 
 
8 
(1244) 
 
9 
(874) 
 
10 
(532) 
 
11 
(521) 
 
12 
(521) 
 
 
 
 
 
Percent of Use 
 
Licit Substances 
 
     Tobacco 
 
     Alcohol 
 
Illicit Substances 
 
     Marijuana 
 
     Cocaine 
 
     Inhalants 
 
     Hallucinogens 
 
     Methamphetamine 
 
     Any illicit 
substance 
 
 
 
10.24 
 
23.21 
 
 
 
7.85 
 
6.66 
 
12.20 
 
4.44 
 
2.99 
 
22.70 
 
 
 
19.66 
 
37.24 
 
 
 
12.66 
 
8.01 
 
15.35 
 
5.25 
 
3.91 
 
28.82 
 
 
 
25.16 
 
43.49 
 
 
 
19.69 
 
11.66 
 
18.97 
 
8.68 
 
8.04 
 
35.77 
 
 
 
30.78 
 
52.86 
 
 
 
23.91 
 
8.70 
 
18.88 
 
9.38 
 
4.58 
 
38.67 
 
 
 
36.28 
 
62.97 
 
 
 
29.32 
 
10.71 
 
17.67 
 
10.90 
 
5.83 
 
41.92 
 
 
 
35.12 
 
64.68 
 
 
 
33.78 
 
12.86 
 
19.39 
 
12.09 
 
8.25 
 
46.64 
 
 
 
44.53 
 
71.98 
 
 
 
39.16 
 
11.13 
 
17.85 
 
12.09 
 
6.72 
 
50.11 
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Table 3.  
 
Logistic Regression Analysis Predicting Lifetime Tobacco Use 
 
 
  
 
B 
 
Wald 
 
OR 
 
 
95% CI 
 
 
 
Step 1 
     SES 
     Grade** 
     Race/Ethnicity 
     Gender 
     
Step 2 
     SES 
     Grade** 
     Race/Ethnicity* 
     Gender 
     Major Depressive Disorder** 
     Separation Anxiety Disorder* 
     Panic Disorder** 
     Generalized Anxiety Disorder* 
     Social Phobia Disorder** 
     Obsessive-Compulsive Disorder 
 
 
 
-0.00 
0.30 
-0.12 
0.06 
 
 
0.01 
0.31 
-0.22 
0.08 
0.03 
-0.01 
0.02 
0.01 
-0.04 
-0.00 
 
 
0.01 
307.19 
2.74 
0.77 
 
 
0.18 
300.67 
8.24 
1.42 
61.92 
6.33 
37.20 
9.69 
78.80 
0.20 
 
 
1.00 
1.35 
0.09 
0.38 
 
 
1.01 
1.36 
0.80 
1.08 
1.03 
0.99 
1.02 
1.01 
0.96 
1.00 
 
 
0.96-1.04 
1.31-1.40 
0.77-1.02 
0.93-1.20 
 
 
0.97-1.06 
1.32-1.41 
0.95-1.23 
0.95-1.23 
1.02-1.04 
0.98-1.00 
1.02-1.03 
1.01-1.02 
0.95-0.97 
0.99-1.01 
 
 
Note. OR = Odds Ratio; CI = Confidence Interval. 
 
* p < .05; ** p < .001.  
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Table 4.  
 
Logistic Regression Analysis Predicting Lifetime Alcohol Use 
 
 
  
 
B 
 
Wald 
 
OR 
 
 
95% CI 
 
 
 
Step 1 
     SES** 
     Grade** 
     Race/Ethnicity 
     Gender* 
     
Step 2 
     SES** 
     Grade** 
     Race/Ethnicity 
     Gender* 
     Major Depressive Disorder** 
     Separation Anxiety Disorder** 
     Panic Disorder** 
     Generalized Anxiety Disorder** 
     Social Phobia Disorder** 
     Obsessive-Compulsive Disorder 
 
 
 
-0.09 
0.38 
-0.03 
0.14 
 
 
-0.09 
0.39 
-0.11 
0.15 
0.02 
-0.02 
0.02 
0.02 
-0.03 
-0.00 
 
 
 
20.42 
525.45 
0.17 
6.06 
 
 
17.91 
521.46 
2.79 
6.84 
38.49 
34.68 
23.53 
30.22 
64.91 
0.31 
 
 
0.91 
1.47 
0.97 
1.15 
 
 
0.92 
1.48 
0.90 
1.16 
1.02 
0.98 
1.02 
1.02 
0.97 
1.00 
 
 
 
0.88-0.95 
1.42-1.52 
0.86-1.10 
1.03-1.29 
 
 
0.88-0.95 
1.43-1.53 
0.79-1.02 
1.04-1.31 
1.01-1.03 
0.97-0.99 
1.01-1.03 
1.01-1.03 
0.96-0.98 
0.99-1.01 
 
 
 
Note. OR = Odds Ratio; CI = Confidence Interval. 
 
* p < .05; ** p < .001. 
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Table 5.  
 
Logistic Regression Analysis Predicting Lifetime Marijuana Use 
 
 
  
 
B 
 
Wald 
 
OR 
 
 
95% CI 
 
 
 
Step 1 
     SES* 
     Grade** 
     Race/Ethnicity 
     Gender** 
     
Step 2 
     SES** 
     Grade** 
     Race/Ethnicity 
     Gender** 
     Major Depressive Disorder** 
     Separation Anxiety Disorder 
     Panic Disorder** 
     Generalized Anxiety Disorder 
     Social Phobia Disorder** 
     Obsessive-Compulsive Disorder* 
 
 
 
0.06 
0.32 
0.15 
0.48 
 
 
0.08 
0.32 
0.11 
0.47 
0.03 
-0.00 
0.02 
0.00 
-0.04 
-0.01 
 
 
6.95 
297.58 
3.56 
46.43 
 
 
10.30 
281.97 
1.73 
42.77 
53.76 
0.54 
24.64 
0.41 
74.03 
3.95 
 
 
1.07 
1.38 
1.16 
1.61 
 
 
1.08 
1.38 
1.11 
1.60 
1.03 
1.00 
1.02 
1.00 
0.96 
0.99 
 
 
1.02-1.12 
1.33-1.43 
0.99-1.36 
1.41-1.85 
 
 
1.03-1.14 
1.33-1.43 
0.95-1.31 
1.39-1.84 
1.02-1.04 
0.99-1.01 
1.01-1.03 
0.99-1.01 
0.95-0.97 
0.98-1.00 
 
 
Note. OR = Odds Ratio; CI = Confidence Interval. 
 
* p < .05; ** p < .001. 
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Table 6.  
 
Logistic Regression Analysis Predicting Lifetime Cocaine Use 
 
 
  
 
B 
 
Wald 
 
OR 
 
 
95% CI 
 
 
 
Step 1 
     SES 
     Grade** 
     Race/Ethnicity 
     Gender** 
     
Step 2 
     SES 
     Grade* 
     Race/Ethnicity 
     Gender** 
     Major Depressive Disorder** 
     Separation Anxiety Disorder* 
     Panic Disorder** 
     Generalized Anxiety Disorder 
     Social Phobia Disorder** 
     Obsessive-Compulsive Disorder 
 
 
 
0.01 
0.09 
0.04 
0.41 
 
 
0.03 
0.08 
-0.03 
0.41 
0.02 
0.01 
0.02 
-0.00 
-0.04 
-0.00 
 
 
0.06 
13.95 
0.16 
19.44 
 
 
0.57 
10.04 
0.08 
18.46 
11.39 
6.83 
10.75 
0.07 
33.52 
0.23 
 
 
1.01 
1.10 
1.04 
1.51 
 
 
1.03 
1.08 
0.97 
1.50 
1.02 
1.01 
1.02 
1.00 
0.96 
1.00 
 
 
0.95-1.07 
1.05-1.15 
0.85-1.28 
1.26-1.81 
 
 
0.96-1.09 
1.03-1.14 
0.79-1.20 
1.25-1.81 
1.01-1.03 
1.00-1.02 
1.01-1.03 
0.99-1.01 
0.95-0.98 
0.99-1.01 
 
 
Note. OR = Odds Ratio; CI = Confidence Interval. 
 
* p < .05; ** p < .001. 
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Table 7.  
 
Logistic Regression Analysis Predicting Lifetime Inhalant Use 
 
 
  
 
B 
 
Wald 
 
OR 
 
 
95% CI 
 
 
 
Step 1 
     SES 
     Grade** 
     Race/Ethnicity 
     Gender 
     
Step 2 
     SES 
     Grade** 
     Race/Ethnicity 
     Gender 
     Major Depressive Disorder** 
     Separation Anxiety Disorder* 
     Panic Disorder** 
     Generalized Anxiety Disorder 
     Social Phobia Disorder** 
     Obsessive-Compulsive Disorder 
 
 
 
-0.03 
0.08 
0.06 
0.08 
 
 
-0.02 
0.08 
-0.05 
0.11 
0.03 
-0.01 
0.02 
0.01 
-0.03 
0.01 
 
 
1.26 
15.92 
0.50 
1.14 
 
 
0.68 
13.90 
0.28 
2.30 
59.50 
5.16 
27.62 
1.75 
46.61 
1.20 
 
 
0.97 
1.08 
1.06 
1.08 
 
 
0.98 
1.08 
0.96 
1.12 
1.03 
0.99 
1.02 
1.01 
.97 
1.01 
 
 
0.93-1.02 
1.04-1.12 
0.90-1.24 
0.94-1.24 
 
 
0.93-1.03 
1.04-1.12 
0.81-1.13 
0.97-1.30 
1.02-1.04 
0.98-1.00 
1.01-1.03 
1.00-1.02 
0.96-0.98 
1.00-1.02 
 
 
Note. OR = Odds Ratio; CI = Confidence Interval. 
 
* p < .05; ** p < .001. 
 
 
 
 
 
 
 
                                
 
78 
 
Table 8.  
 
Logistic Regression Analysis Predicting Lifetime Hallucinogen Use 
 
 
  
 
B 
 
Wald 
 
OR 
 
 
95% CI 
 
 
 
Step 1 
     SES 
     Grade** 
     Race/Ethnicity 
     Gender** 
     
Step 2 
     SES 
     Grade** 
     Race/Ethnicity* 
     Gender** 
     Major Depressive Disorder** 
     Separation Anxiety Disorder* 
     Panic Disorder** 
     Generalized Anxiety Disorder* 
     Social Phobia Disorder** 
     Obsessive-Compulsive Disorder 
 
 
 
-0.00 
0.22 
-0.23 
0.60 
 
 
0.02 
0.21 
-0.33 
0.59 
0.02 
0.01 
0.04 
-0.02 
-0.05 
0.00 
 
 
0.01 
65.88 
3.70 
32.17 
 
 
0.38 
54.67 
6.93 
30.19 
10.74 
3.84 
35.96 
5.72 
42.57 
0.02 
 
 
1.00 
1.25 
0.79 
1.81 
 
 
1.02 
1.23 
0.72 
1.81 
1.02 
1.01 
1.04 
0.98 
0.95 
1.00 
 
 
0.93-1.07 
1.18-1.31 
0.63-1.00 
1.48-2.23 
 
 
0.95-1.10 
1.16-1.30 
0.56-0.92 
1.46-2.23 
1.01-1.03 
1.00-1.02 
1.02-1.05 
0.97-1.00 
0.94-0.97 
0.99-1.02 
 
 
Note. OR = Odds Ratio; CI = Confidence Interval. 
 
* p < .05; ** p < .001. 
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Table 9.  
 
Logistic Regression Analysis Predicting Lifetime Methamphetamine Use 
 
 
  
 
B 
 
Wald 
 
OR 
 
 
95% CI 
 
 
 
Step 1 
     SES 
     Grade** 
     Race/Ethnicity* 
     Gender** 
     
Step 2 
     SES 
     Grade** 
     Race/Ethnicity* 
     Gender** 
     Major Depressive Disorder* 
     Separation Anxiety Disorder* 
     Panic Disorder** 
     Generalized Anxiety Disorder* 
     Social Phobia Disorder** 
     Obsessive-Compulsive Disorder 
 
 
 
-0.02 
0.14 
0.39 
0.62 
 
 
0.01 
0.12 
0.30 
0.61 
0.01 
0.02 
0.04 
-0.02 
-0.05 
-0.00 
 
 
0.25 
17.86 
7.44 
23.39 
 
 
0.04 
11.55 
4.27 
21.46 
4.22 
8.46 
29.37 
3.06 
32.10 
0.21 
 
 
0.98 
1.15 
1.48 
1.86 
 
 
1.01 
1.12 
1.36 
1.84 
1.01 
1.02 
1.04 
0.99 
0.95 
1.00 
 
 
0.90-1.06 
1.08-1.23 
1.12-1.95 
1.45-2.40 
 
 
0.93-1.10 
1.05-1.20 
1.02-1.81 
1.42-2.38 
1.00-1.03 
1.01-1.03 
1.03-1.05 
0.97-1.00 
0.94-.0.97 
0.98-1.01 
 
 
Note. OR = Odds Ratio; CI = Confidence Interval. 
 
* p < .05; ** p < .001. 
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Figure 1 
Overall Trends in Lifetime Use by Grade and Substance 
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Revised Child Anxiety and Depression Scale (RCADS) 
Please put a circle around the word that shows how often each of these things happen to you. 
There are no right or wrong answers. 
 
 Never Sometimes Often Always 
1. I worry about things . . . . . . . . . . . . . .  Never Sometimes Often Always 
2. I feel sad or empty . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
3. When I have a problem, I get a funny 
feeling in my stomach . . . . . . . . . . . . .  Never Sometimes Often Always 
4. I worry when I think I have done 
poorly at something . . . . . . . . . . . . . . .  Never Sometimes Often Always 
5. I would feel afraid of being on my 
own at home . . . . . . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
6. Nothing is much fun anymore . . . . . .  Never Sometimes Often Always 
7. I feel scared when I have to take a test  Never Sometimes Often Always 
8. I feel worried when I think someone 
is angry with me . . . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
9. I worry about being away from my 
parents . . . . . . . . . . . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
10. I get bothered by bad or silly 
thoughts or pictures in my mind . . . . .  Never Sometimes Often Always 
11. I have trouble sleeping . . . . . . . . . . . . .  Never Sometimes Often Always 
12. I worry that I will do badly at my 
school work . . . . . . . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
13. I worry that something awful will 
happen to someone in my family . . . .  Never Sometimes Often Always 
14. I suddenly feel as if I can't breathe 
when there is no reason for this . . . . .  Never Sometimes Often Always 
15. I have problems with my appetite . . .  Never Sometimes Often Always 
16. I have to keep checking that I have 
done things right (like the switch is 
off, or the door is locked) . . . . . . . . . . .  
Never Sometimes Often Always 
17. I feel scared if I have to sleep on my 
own . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Never Sometimes Often Always 
18. I have trouble going to school in the 
mornings because I feel nervous or 
afraid . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Never Sometimes Often Always 
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19. I have no energy for things . . . . . . . . .  Never Sometimes Often Always 
20. I worry I might look foolish . . . . . . . .  Never Sometimes Often Always 
21. I am tired a lot . . . . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
22. I worry that bad things will happen to 
me . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Never Sometimes Often Always 
23. I can't seem to get bad or silly 
thoughts out of my head  . . . . . . . . . . .  Never Sometimes Often Always 
24. When I have a problem, my heart 
beats really fast . . . . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
25. I cannot think clearly . . . . . . . . . . . . . .  Never Sometimes Often Always 
26. I suddenly start to tremble or shake 
when there is no reason for this . . . . .  Never Sometimes Often Always 
27. I worry that something bad will 
happen to me . . . . . . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
28. When I have a problem, I feel shaky  Never Sometimes Often Always 
29. I feel worthless . . . . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
30. I worry about making mistakes . . . . .  Never Sometimes Often Always 
31. I have to think of special thoughts 
(like numbers or words) to stop bad 
things from happening. . . . . . . . . . . . .  
Never Sometimes Often Always 
32. I worry what other people think of 
me . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Never Sometimes Often Always 
33. I am afraid of being in crowded 
places (like shopping centers, the 
movies, buses, busy playgrounds) . . . .  
Never Sometimes Often Always 
34. All of a sudden I feel really scared for 
no reason at all . . . . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
35. I worry about what is going to 
happen . . . . . . . . . . . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
36. I suddenly become dizzy or faint 
when there is no reason for this . . . . .  Never Sometimes Often Always 
37. I think about death . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
38. I feel afraid if I have to talk in front 
of my class . . . . . . . . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
39. My heart suddenly starts to beat too 
quickly for no reason . . . . . . . . . . . . . .  Never Sometimes Often Always 
40. I feel like I don’t want to move . . . . . .  Never Sometimes Often Always 
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41. I worry that I will suddenly get a 
scared feeling when there is nothing 
to be afraid of . . . . . . . . . . . . . . . . . . . .  
Never Sometimes Often Always 
42. I have to do some things over and 
over again (like washing my hands, 
cleaning or putting things in a certain 
order) . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Never Sometimes Often Always 
43. I feel afraid that I will make a fool of 
myself in front of people   Never Sometimes Often Always 
44. I have to do some things in just the 
right way to stop bad things from 
happening . . . . . . . . . . . . . . . . . . . . . . .  
Never Sometimes Often Always 
45. I worry when I go to bed at night . . . .  Never Sometimes Often Always 
46. I would feel scared if I had to stay 
away from home overnight . . . . . . . . .  Never Sometimes Often Always 
47. I feel restless . . . . . . . . . . . . . . . . . . . . .  Never Sometimes Often Always 
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Modified Youth Risk Behavior Survey (YRBS) 
 
Directions: Please bubble in the letter of the answer choice that best describes your 
response to following questions.  
 
1. Have you ever carried a weapon, such as a gun, knife, or club? 
A. Yes  B. No 
 
2. Have you ever been in a physical fight? 
A. Yes  B. No 
 
3. In the past 30 days have you been in a physical fight? 
A. Yes  B. No 
 
4. Have you ever been in a physical fight in which you were hurt and had to be treated by a 
doctor or nurse? 
A. Yes  B. No 
 
5. Have you ever been in a physical fight where you tried to use a weapon to hurt someone? 
A. Yes  B. No 
 
6. Have you ever been bullied on school property? Bullying is when one or more students tease, 
threaten, spread rumors about, hit, shove, or hurt another student over and over again. It is not 
bullying when two students of about the same strength or power argue or fight or tease each 
other in a friendly way. 
A. Yes  B. No 
 
7. Have you ever seriously thought about killing yourself? 
A. Yes  B. No 
 
8. Have you ever made a plan about how you would kill yourself? 
A. Yes  B. No 
 
9. Have you ever tried to kill yourself? 
A. Yes  B. No 
 
10. Have you ever tried cigarette smoking? 
A. Yes  B. No 
 
11. How old were you when you smoked a whole cigarette for the first time? 
A. I have never smoked a whole cigarette  
B. Younger than 10  
C. 10-13  
D. 13-15  
E. Older than 15 
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12. During the past 30 days, on how many days did you smoke cigarettes? 
A. 0  
B. 1-9  
C. 10-19  
D. 20-29  
E. 30 (every day) 
 
13. During the past 30 days, on the days you smoked, how many cigarettes did you smoke per 
day? 
A. I did not smoke cigarettes during the past 30 days.  
B. 1-5  
C. 6-10  
D. 11-15  
E. More than 15 
 
14. During the past 30 days, how did you usually get your cigarettes? 
A. I did not smoke cigarettes during the past 30 days.  
B. I bought them myself.  
C. I got someone else to buy them for me. 
D. Someone gave them to me E. I took them from a store or family member. 
 
15. Have you ever smoked cigarettes daily, that is, at least one cigarette every day for 30 days? 
A. Yes  B. No 
 
16. During the past 30 days, on how many days did you use chewing tobacco, snuff, or dip? 
A. 0  
B. 1-9  
C. 10-19  
D. 20-29  
E. 30 (every day) 
 
17. During the past 30 days, on how many days did you smoke cigars, cigarillos, or little cigars? 
A. 0  
B. 1-9  
C. 10-19  
D. 20-29  
E. 30 (every day) 
 
18. Have you ever had a drink of alcohol (more than just a sip)? 
A. Yes  B. No 
 
19. How old were you when you had your first drink of alcohol (more than just a sip)? 
A. I have never had a drink of alcohol  
B. Younger than 10  
C. 10-13  
D. 13-15  
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E. Older than 15 
 
20. During the past 30 days, on how many days did you drink alcohol? 
A. 0  
B. 1-9  
C. 10-19  
D. 20-29  
E. 30 (every day) 
 
21. Have you ever used marijuana (also called weed, grass, or pot)? 
A. Yes  B. No 
 
22. How old were you when you tried marijuana for the first time? 
A. I have never tried marijuana  
B. Younger than 10  
C. 10-13  
D. 13-15  
E. Older than 15 
 
23. During the past 30 days, on how many days did you use marijuana? 
A. 0  
B. 1-9  
C. 10-19  
D. 20-29  
E. 30 (every day) 
 
24. Have you ever used any form of cocaine, including powder, crack, or freebase? 
A. Yes  B. No 
 
25. How old were you when you tried cocaine for the first time? 
A. I have never tried cocaine  
B. Younger than 10  
C. 10-13  
D. 13-15  
E. Older than 15 
 
26. During the past 30 days, on how many days did you use cocaine? 
A. 0  
B. 1-9  
C. 10-19  
D. 20-29  
E. 30 (every day) 
 
27. Have you ever sniffed glue, breathed the contents of spray cans, or inhaled other things (like 
paint, gas, or lighter fluid) to get high? 
A. Yes  B. No 
                                
 
87 
 
 
28. How old were you when you inhaled something to get high for the first time? 
A. I have never inhaled something to get high  
B. Younger than 10  
C. 10-13  
D. 13-15  
E. Older than 15 
 
29. During the past 30 days, on how many days did you inhale something to get high? 
A. 0  
B. 1-9  
C. 10-19  
D. 20-29  
E. 30 (every day) 
 
30. Have you ever taken drugs to make yourself hallucinate, like LSD (also called acid), 
mescaline (also called cactus), or Salvia (also called magic mint or diviner’s sage)? 
A. Yes  B. No 
 
31. Have you ever used methamphetamines (also called crystal meth, meth, crank, ice, or tick 
tick)? 
A. Yes  B. No 
 
32. Have you ever used prescription drugs to get high? 
A. Yes  B. No 
 
33. During the past 30 days, on how many days did you use prescription drugs to get high? 
A. 0  
B. 1-9  
C. 10-19  
D. 20-29  
E. 30 (every day) 
 
34. How do you usually get prescription drugs used to get high? 
A. I have never used prescription drugs to get high  
B. I use my own  
C. I use my friends’  
D. I buy them 
E. I take them from a family member 
 
35. Have you ever used a prescription stimulant, like Ritalin, Concerta, Focalin, or Dexedrine, to 
get high? 
A. Yes  B. No 
 
36. Have you ever used a prescription antipsychotic, like Seroquel, Abilify, Geodon, or 
Risperdal, to get high? 
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A. Yes  B. No 
 
37. Have you ever used a prescription benzodiazepene, like Valium, Xanax, or Klonopin, to get 
high? 
A. Yes  B. No 
 
38. Have you ever used a prescription SSRI, like Prozac, Paxil, Luvox, Lexapro, Celexa, or 
Zoloft, to get high? 
A. Yes  B. No 
 
39. Have you ever used prescription pain pills, like Vicodin, Percocet, OxyContin, Codeine, or 
Demerol, to get high? 
A. Yes  B. No 
 
40. Have you ever taken pills with alcohol to get high? 
A. Yes  B. No 
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ADDITIONAL EXPERIENCE 
 
Clinical Assessment: 
• Structured Clinical Interview for DSM-IV (SCID-IV) (67) 
• Clinician Administered PTSD Scale (CAPS) (83) 
• Diagnostic Interview for Personality Disorders (DIPD) – Borderline Personality Module (87) 
• Diagnostic Interview for Personality Disorders (DIPD) – Avoidant Personality Module (39) 
 
Research: 
• Experience in the development and programming of information processing tasks (e.g., the 
Implicit Association Task, Dot-Probe Attentional Bias Task).  
• Experience in creating data sets in SPSS, as well as the analysis of data using SPSS. 
• Experience in administering information processing (e.g., Dot-Probe) and behavioral tasks 
(e.g., the Balloon Analogue Risk-Taking Task [BART] and the Paced Auditory Serial 
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